{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:22:16Z","timestamp":1794021736210,"version":"4.8.0"},"reference-count":407,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100010969","name":"Alzheimer Nederland","doi-asserted-by":"publisher","award":["WE.03-2021-05"],"award-info":[{"award-number":["WE.03-2021-05"]}],"id":[{"id":"10.13039\/501100010969","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010969","name":"Alzheimer Nederland","doi-asserted-by":"publisher","award":["WE.03-2021-05"],"award-info":[{"award-number":["WE.03-2021-05"]}],"id":[{"id":"10.13039\/501100010969","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immun Ageing"],"DOI":"10.1186\/s12979-025-00529-5","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T05:50:35Z","timestamp":1755755435000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Systemic inflammation as a central player in the initiation and development of Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"22","author":[{"given":"Irem","family":"Bayraktaroglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Ort\u00ed-Casa\u00f1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debby","family":"Van Dam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter P.","family":"De Deyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich L. M.","family":"Eisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"key":"529_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.molmed.2007.12.002","volume":"14","author":"P Reddy Hemachandra","year":"2008","unstructured":"Reddy Hemachandra P, Flint Beal M. Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and alzheimer\u2019s disease. Trends Mol Med. 2008;14:45\u201353.","journal-title":"Trends Mol Med"},{"key":"529_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nrneurol.2011.2","volume":"7","author":"C Reitz","year":"2011","unstructured":"Reitz C, Brayne C, Mayeux R. Epidemiology of alzheimer disease. Nat Rev Neurol. 2011;7:137\u201352.","journal-title":"Nat Rev Neurol"},{"key":"529_CR3","doi-asserted-by":"publisher","first-page":"a004457","DOI":"10.1101\/cshperspect.a004457","volume":"3","author":"DJ Selkoe","year":"2011","unstructured":"Selkoe DJ. Alzheimer\u2019s disease. Cold Spring Harb Perspect Biol. 2011;3:a004457.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"529_CR4","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, Khoury J, El, Landreth GE, Brosseron F, Feinstein DL, et al. Neuroinflammation in alzheimer\u2019s disease. Lancet Neurol. 2015;14:388\u2013405.","journal-title":"Lancet Neurol"},{"key":"529_CR5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11910-020-01090-y","volume":"2","author":"T Ayodele","year":"2021","unstructured":"Ayodele T, Rogaeva E, Kurup JT, Beecham G, Reitz C. Early-Onset alzheimer\u2019s disease: what is missing in research?? Curr Neurol Neurosci Rep. 2021;2:4.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"529_CR6","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.ncl.2007.03.009","volume":"25","author":"N Ertekin-Taner","year":"2007","unstructured":"Ertekin-Taner N. Genetics of alzheimer\u2019s disease: A centennial review. Neurol Clin. 2007;25:611\u2013v.","journal-title":"Neurol Clin"},{"key":"529_CR7","doi-asserted-by":"publisher","first-page":"104511","DOI":"10.1016\/j.ebiom.2023.104511","volume":"90","author":"SJ Andrews","year":"2023","unstructured":"Andrews SJ, Renton AE, Fulton-Howard B, Podlesny-Drabiniok A, Marcora E, Goate AM. The complex genetic architecture of alzheimer\u2019s disease: novel insights and future directions. EbioMedicine. 2023;90:104511.","journal-title":"EbioMedicine"},{"key":"529_CR8","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1086\/302553","volume":"65","author":"D Campion","year":"1999","unstructured":"Campion D, Dumanchin C, Hannequin D, Dubois B, Belliard S, Puel M, et al. Early-Onset autosomal dominant alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet. 1999;65:664\u201370.","journal-title":"Am J Hum Genet"},{"key":"529_CR9","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ. The amyloid hypothesis of alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science. 2002;297:353\u20136.","journal-title":"Science"},{"key":"529_CR10","doi-asserted-by":"publisher","first-page":"14499","DOI":"10.3390\/ijms241914499","volume":"24","author":"E Fedele","year":"2023","unstructured":"Fedele E. Anti-Amyloid therapies for alzheimer\u2019s disease and the amyloid cascade hypothesis. Int J Mol Sci. 2023;24:14499.","journal-title":"Int J Mol Sci"},{"key":"529_CR11","doi-asserted-by":"crossref","unstructured":"Behl C. In. 2024, the amyloid-cascade-hypothesis still remains a working hypothesis, no less but certainly no more. Front Aging Neurosci. 2024;16:1459224.","DOI":"10.3389\/fnagi.2024.1459224"},{"key":"529_CR12","doi-asserted-by":"publisher","first-page":"3969","DOI":"10.1093\/brain\/awad159","volume":"146","author":"KP Kepp","year":"2023","unstructured":"Kepp KP, Robakis NK, H\u00f8ilund-Carlsen PF, Sensi SL, Vissel B. The amyloid cascade hypothesis: an updated critical review. Brain. 2023;146:3969\u201390.","journal-title":"Brain"},{"key":"529_CR13","first-page":"e12589","volume":"16","author":"L Bl\u00f6meke","year":"2024","unstructured":"Bl\u00f6meke L, Rehn F, Kraemer-Schulien V, Kutzsche J, Pils M, Bujnicki T, et al. A\u03b2 oligomers peak in early stages of alzheimer\u2019s disease preceding Tau pathology. Alzheimer\u2019s Dementia: Diagnosis Assess Disease Monit. 2024;16:e12589.","journal-title":"Alzheimer\u2019s Dementia: Diagnosis Assess Disease Monit"},{"key":"529_CR14","doi-asserted-by":"publisher","first-page":"e14415","DOI":"10.1002\/alz.14415","volume":"21","author":"R Cacciaglia","year":"2025","unstructured":"Cacciaglia R, Falc\u00f3n C, Benavides GS, Brugulat-Serrat A, Alom\u00e0 MM, Calvet MS, et al. Soluble A\u03b2 pathology predicts neurodegeneration and cognitive decline independently on p-tau in the earliest alzheimer\u2019s continuum: evidence across two independent cohorts. Alzheimer\u2019s Dement. 2025;21:e14415.","journal-title":"Alzheimer\u2019s Dement"},{"key":"529_CR15","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12974-024-03208-2","volume":"21","author":"J Zou","year":"2024","unstructured":"Zou J, McNair E, DeCastro S, Lyons SP, Mordant A, Herring LE, et al. Microglia either promote or restrain TRAIL-mediated excitotoxicity caused by A\u03b21\u2013\u200942 oligomers. J Neuroinflammation. 2024;21:215.","journal-title":"J Neuroinflammation"},{"key":"529_CR16","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1212\/01.WNL.0000115115.98960.37","volume":"62","author":"M Ingelsson","year":"2004","unstructured":"Ingelsson M, Fukumoto H, Newell K, Growdon J, Hedley-Whyte E, Frosch M, et al. Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology. 2004;62:925\u201331.","journal-title":"Neurology"},{"key":"529_CR17","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.hlife.2024.11.006","volume":"3","author":"A Ghimire","year":"2025","unstructured":"Ghimire A, Rehman SA, Subhani A, Khan MA, Rahman Z, Iqubal MK, et al. Mechanism of microglia-mediated neuroinflammation, associated cognitive dysfunction, and therapeutic updates in alzheimer\u2019s disease. hLife. 2025;3:64\u201381.","journal-title":"hLife"},{"key":"529_CR18","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1007\/s00702-006-0575-6","volume":"113","author":"P Eikelenboom","year":"2006","unstructured":"Eikelenboom P, Veerhuis R, Scheper W, Rozemuller AJM, Van Gool WA, Hoozemans JJM. The significance of neuroinflammation in Understanding alzheimer\u2019s disease. J Neural Transm. 2006;113:1685\u201395.","journal-title":"J Neural Transm"},{"key":"529_CR19","doi-asserted-by":"publisher","first-page":"652111","DOI":"10.3389\/fncel.2021.652111","volume":"15","author":"J Lutshumba","year":"2021","unstructured":"Lutshumba J, Nikolajczyk BS, Bachstetter AD. Dysregulation of systemic immunity in aging and dementia. Front Cell Neurosci. 2021;15:652111.","journal-title":"Front Cell Neurosci"},{"key":"529_CR20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11910-020-01090-y","volume":"21","author":"T Ayodele","year":"2021","unstructured":"Ayodele T, Rogaeva E, Kurup JT, Beecham G, Reitz C. Early-Onset alzheimer\u2019s disease: what is missing in research?? Curr Neurol Neurosci Rep. 2021;21:4.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"529_CR21","doi-asserted-by":"publisher","first-page":"e512","DOI":"10.1212\/NXG.0000000000000512","volume":"6","author":"C Reitz","year":"2020","unstructured":"Reitz C, Rogaeva E, Beecham GW. Late-onset vs nonmendelian early-onset alzheimer disease - A distinction without a difference? Neurol Genet. 2020;6:e512.","journal-title":"Neurol Genet"},{"key":"529_CR22","doi-asserted-by":"publisher","first-page":"S64","DOI":"10.1002\/alz.13482","volume":"19","author":"KNH Nudelman","year":"2023","unstructured":"Nudelman KNH, Jackson T, Rumbaugh M, Eloyan A, Abreu M, Dage JL, et al. Pathogenic variants in the longitudinal Early-onset alzheimer\u2019s disease study cohort. Alzheimer\u2019s Dement. 2023;19:S64\u201373.","journal-title":"Alzheimer\u2019s Dement"},{"key":"529_CR23","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.neuron.2017.09.056","volume":"96","author":"NJ Allen","year":"2017","unstructured":"Allen NJ, Eroglu C. Cell biology of astrocyte-synapse interactions. Neuron. 2017;96:697\u2013708.","journal-title":"Neuron"},{"key":"529_CR24","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1002\/glia.20990","volume":"58","author":"TM Mathiisen","year":"2010","unstructured":"Mathiisen TM, Lehre KP, Danbolt NC, Ottersen OP. The perivascular astroglial sheath provides a complete covering of the brain microvessels: an electron microscopic 3D reconstruction. Glia. 2010;58:1094\u2013103.","journal-title":"Glia"},{"key":"529_CR25","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1172\/JCI90602","volume":"9","author":"K Kierdorf","year":"2017","unstructured":"Kierdorf K, Prinz M. Microglia in steady state. Jorunal Clin Invest. 2017;9:3201\u20139.","journal-title":"Jorunal Clin Invest"},{"key":"529_CR26","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s11481-007-9069-z","volume":"2","author":"DL Herber","year":"2007","unstructured":"Herber DL, Mercer M, Roth LM, Symmonds K, Maloney J, Wilson N, et al. Microglial activation is required for A\u03b2 clearance after intracranial injection of lipopolysaccharide in APP Transgenic mice. J Neuroimmune Pharmacol. 2007;2:222\u201331.","journal-title":"J Neuroimmune Pharmacol"},{"issue":"43","key":"529_CR27","doi-asserted-by":"publisher","first-page":"10939","DOI":"10.1523\/JNEUROSCI.2085-06.2006","volume":"26","author":"KJ Yin","year":"2006","unstructured":"Yin KJ, Cirrito JR, Yan P, Hu X, Xiao Q, Pan X, et al. Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-\u03b2 peptide catabolism. J Neurosci. 2006;26(43):10939\u201348.","journal-title":"J Neurosci"},{"key":"529_CR28","unstructured":"van Olst L, Simonton B, Edwards AJ, Forsyth AV, Boles J, Jamshidi P et al. Microglial mechanisms drive amyloid-\u03b2 clearance in immunized patients with alzheimer\u2019s disease. Nat Med. 2025;s41591-025-03574\u20131."},{"key":"529_CR29","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1126\/science.1197623","volume":"330","author":"KG Mawuenyega","year":"2010","unstructured":"Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC, et al. Decreased clearance of CNS Amyloid-\u03b2 in alzheimer\u2019s disease. Science. 2010;330:1774.","journal-title":"Science"},{"key":"529_CR30","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1146\/annurev-physiol-022516-034406","volume":"79","author":"SA Wolf","year":"2017","unstructured":"Wolf SA, Boddeke HWGM, Kettenmann H. Microglia in physiology and disease. Annual Rev Physiol. 2017;79:619\u201343.","journal-title":"Annual Rev Physiol"},{"key":"529_CR31","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/sj.cdd.4401837","volume":"13","author":"MP Mattson","year":"2006","unstructured":"Mattson MP, Meffert MK. Roles for NF-kappaB in nerve cell survival, plasticity, and disease. Cell Death Differ. 2006;13:852\u201360.","journal-title":"Cell Death Differ"},{"key":"529_CR32","doi-asserted-by":"publisher","first-page":"18372","DOI":"10.1073\/pnas.0907652106","volume":"106","author":"K Ghosal","year":"2009","unstructured":"Ghosal K, Vogt DL, Liang M, Shen Y, Lamb BT, Pimplikar SW. Alzheimer\u2019s disease-like pathological features in Transgenic mice expressing the APP intracellular domain. Proc Natl Acad Sci U S A. 2009;106:18372.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"529_CR33","doi-asserted-by":"publisher","first-page":"49523","DOI":"10.1074\/jbc.M402034200","volume":"19","author":"YF Liao","year":"2004","unstructured":"Liao YF, Wang BJ, Cheng HT, Kuo LH, Wolfe MS. Tumor necrosis Factor-\u03b1, Interleukin-1\u03b2, and Interferon-\u03b3 stimulate \u03b3-Secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathway. J Biol Chem. 2004;19:279:49523\u201332.","journal-title":"J Biol Chem"},{"key":"529_CR34","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s12272-010-1006-7","volume":"33","author":"YJ Lee","year":"2010","unstructured":"Lee YJ, Han SB, Nam SY, Oh KW, Hong JT. Inflammation and alzheimer\u2019s disease. Arch Pharm Res. 2010;33:1539\u201356.","journal-title":"Arch Pharm Res"},{"key":"529_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neures.2013.10.004","volume":"79","author":"M Lyman","year":"2014","unstructured":"Lyman M, Lloyd DG, Ji X, Vizcaychipi MO, Ma D. Neuroinflammation: the role and consequences. Neurosci Res. 2014;79:1\u201312.","journal-title":"Neurosci Res"},{"key":"529_CR36","doi-asserted-by":"publisher","first-page":"16755","DOI":"10.1523\/JNEUROSCI.4521-10.2010","volume":"30","author":"K Herrup","year":"2010","unstructured":"Herrup K. Reimagining alzheimer\u2019s disease\u2013an age-based hypothesis. J Neurosci. 2010;30:16755\u201362.","journal-title":"J Neurosci"},{"key":"529_CR37","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.coi.2020.10.011","volume":"68","author":"MT Milner","year":"2021","unstructured":"Milner MT, Maddugoda M, G\u00f6tz J, Burgener SS, Schroder K. The NLRP3 inflammasome triggers sterile neuroinflammation and alzheimer\u2019s disease. Curr Opin Immunol. 2021;68:116\u201324.","journal-title":"Curr Opin Immunol"},{"key":"529_CR38","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nri2015","volume":"7","author":"VH Perry","year":"2007","unstructured":"Perry VH, Cunningham C, Holmes C. Systemic infections and inflammation affect chronic neurodegeneration. Nat Rev Immunol. 2007;7:161\u20137.","journal-title":"Nat Rev Immunol"},{"key":"529_CR39","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neuropharm.2014.10.028","volume":"96","author":"DM Norden","year":"2015","unstructured":"Norden DM, Muccigrosso MM, Godbout JP. Microglial priming and enhanced reactivity to secondary insult in aging, and traumatic CNS injury, and neurodegenerative disease. Neuropharmacology. 2015;96:29\u201341.","journal-title":"Neuropharmacology"},{"key":"529_CR40","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12987-020-00187-3","volume":"17","author":"MA Erickson","year":"2020","unstructured":"Erickson MA, Wilson ML, Banks WA. In vitro modeling of blood-brain barrier and interface functions in neuroimmune communication. Fluids Barriers CNS. 2020;17:26.","journal-title":"Fluids Barriers CNS"},{"key":"529_CR41","doi-asserted-by":"publisher","first-page":"13537","DOI":"10.1038\/s41598-017-13601-y","volume":"7","author":"NM Vogt","year":"2017","unstructured":"Vogt NM, Kerby RL, Dill-McFarland KA, Harding SJ, Merluzzi AP, Johnson SC, et al. Gut Microbiome alterations in alzheimer\u2019s disease. Sci Rep. 2017;7:13537.","journal-title":"Sci Rep"},{"key":"529_CR42","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13024-023-00627-2","volume":"18","author":"KA Walker","year":"2023","unstructured":"Walker KA, Le Page LM, Terrando N, Duggan MR, Heneka MT, Bettcher BM. The role of peripheral inflammatory insults in alzheimer\u2019s disease: a review and research roadmap. Mol Neurodegeneration. 2023;18:37.","journal-title":"Mol Neurodegeneration"},{"key":"529_CR43","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1038\/s41423-021-00740-6","volume":"18","author":"Y Huang","year":"2021","unstructured":"Huang Y, Xu W, Zhou R. NLRP3 inflammasome activation and cell death. Cell Mol Immunol. 2021;18:2114\u201327.","journal-title":"Cell Mol Immunol"},{"key":"529_CR44","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.cell.2014.04.007","volume":"157","author":"M Lamkanfi","year":"2014","unstructured":"Lamkanfi M, Dixit VM. Mechanisms and functions of inflammasomes. Cell. 2014;157:1013\u201322.","journal-title":"Cell"},{"key":"529_CR45","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.immuni.2013.08.037","volume":"39","author":"H Wen","year":"2013","unstructured":"Wen H, Miao EA, Ting JPY. Mechanisms of NOD-like receptor-associated inflammasome activation. Immunity. 2013;39:432\u201341.","journal-title":"Immunity"},{"key":"529_CR46","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nature25158","volume":"552","author":"C Venegas","year":"2017","unstructured":"Venegas C, Kumar S, Franklin BS, Dierkes T, Brinkschulte R, Tejera D, et al. Microglia-derived ASC specks crossseed amyloid-\u03b2 in alzheimer\u2019s disease. Nature. 2017;552:355\u201361.","journal-title":"Nature"},{"key":"529_CR47","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","volume":"575","author":"C Ising","year":"2020","unstructured":"Ising C, Venegas C, Zhang S, Scheiblich H, Schmidt SV, Vieira-Saecker A, et al. NLRP3 inflammasome activation drives Tau pathology. Nature. 2020;575:669\u201373.","journal-title":"Nature"},{"issue":"10","key":"529_CR48","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1136\/jnnp-2017-316201","volume":"88","author":"KSP Lai","year":"2017","unstructured":"Lai KSP, Liu CS, Rau A, Lanct\u00f4t KL, K\u00f6hler CA, Pakosh M, et al. Peripheral inflammatory markers in alzheimer\u2019s disease: a systematic review and meta-analysis of 175 studies. J Neurol Neurosurg Psychiatry. 2017;88(10):876\u201382.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"529_CR49","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.biopsych.2010.06.012","volume":"68","author":"W Swardfager","year":"2010","unstructured":"Swardfager W, Lanctt K, Rothenburg L, Wong A, Cappell J, Herrmann N. A Meta-Analysis of cytokines in alzheimer\u2019s disease. Biol Psychiatry. 2010;68:930\u201341.","journal-title":"Biol Psychiatry"},{"key":"529_CR50","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1212\/WNL.0b013e3181b6bb95","volume":"73","author":"C Holmes","year":"2009","unstructured":"Holmes C, Cunningham C, Zotova E, Woolford J, Dean C, Kerr S, et al. Systemic inflammation and disease progression in alzheimer disease. Neurology. 2009;73:774.","journal-title":"Neurology"},{"key":"529_CR51","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1212\/WNL.0b013e318225ae07","volume":"77","author":"C Holmes","year":"2011","unstructured":"Holmes C, Cunningham C, Zotova E, Culliford D, Perry VH. Proinflammatory cytokines, sickness behavior, and alzheimer disease. Neurology. 2011;77:212\u20138.","journal-title":"Neurology"},{"key":"529_CR52","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41586-019-1895-7","volume":"577","author":"D Gate","year":"2020","unstructured":"Gate D, Saligrama N, Leventhal O, Yang AC, Unger MS, Middeldorp J, et al. Clonally expanded CD8 T cells patrol the cerebrospinal fluid in alzheimer\u2019s disease. Nature. 2020;577:404.","journal-title":"Nature"},{"key":"529_CR53","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3233\/JAD-2009-1015","volume":"17","author":"A Larbi","year":"2009","unstructured":"Larbi A, Pawelec G, Witkowski JM, Schipper HM, Derhovanessian E, Goldeck D, et al. Dramatic shifts in Circulating CD4 but not CD8 T cell subsets in mild alzheimer\u2019s disease. J Alzheimer\u2019s Disease. 2009;17:91\u2013103.","journal-title":"J Alzheimer\u2019s Disease"},{"key":"529_CR54","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s12974-021-02308-7","volume":"18","author":"J Machhi","year":"2021","unstructured":"Machhi J, Yeapuri P, Lu Y, Foster E, Chikhale R, Herskovitz J, et al. CD4 + effector T cells accelerate alzheimer\u2019s disease in mice. J Neuroinflammation. 2021;18:272.","journal-title":"J Neuroinflammation"},{"key":"529_CR55","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.bbi.2020.05.070","volume":"89","author":"MS Unger","year":"2020","unstructured":"Unger MS, Li E, Scharnagl L, Poupardin R, Altendorfer B, Mrowetz H, et al. CD8 + T-cells infiltrate alzheimer\u2019s disease brains and regulate neuronal- and synapse-related gene expression in APP-PS1 Transgenic mice. Brain Behav Immun. 2020;89:67\u201386.","journal-title":"Brain Behav Immun"},{"key":"529_CR56","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1038\/s41593-023-01415-3","volume":"26","author":"M Jorfi","year":"2023","unstructured":"Jorfi M, Park J, Hall CK, Lin CCJ, Chen M, von Maydell D, et al. Infiltrating CD8 + T cells exacerbate alzheimer\u2019s disease pathology in a 3D human neuroimmune axis model. Nat Neurosci. 2023;26:1504.","journal-title":"Nat Neurosci"},{"key":"529_CR57","doi-asserted-by":"publisher","first-page":"e2401420121","DOI":"10.1073\/pnas.2401420121","volume":"121","author":"A Panwar","year":"2024","unstructured":"Panwar A, Rentsendorj A, Jhun M, Cohen RM, Cordner R, Gull N, et al. Antigen-specific age-related memory CD8 T cells induce and track Alzheimer\u2019s-like neurodegeneration. Proc Natl Acad Sci U S A. 2024;121:e2401420121.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"529_CR58","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","volume":"133","author":"S Sakaguchi","year":"2008","unstructured":"Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell. 2008;133:775\u201387.","journal-title":"Cell"},{"key":"529_CR59","doi-asserted-by":"publisher","first-page":"8788","DOI":"10.1038\/s41598-019-45433-3","volume":"9","author":"F Ciccocioppo","year":"2019","unstructured":"Ciccocioppo F, Lanuti P, Pierdomenico L, Simeone P, Bologna G, Ercolino E, et al. The characterization of regulatory T-Cell profiles in alzheimer\u2019s disease and multiple sclerosis. Sci Rep. 2019;9:8788.","journal-title":"Sci Rep"},{"key":"529_CR60","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1093\/brain\/awv408","volume":"139","author":"C Dansokho","year":"2016","unstructured":"Dansokho C, Ahmed DA, Aid S, Cile Toly-Ndour C, Chaigneau T, Calle V, et al. Regulatory T cells delay disease progression in Alzheimer-like pathology. Brain. 2016;139:1237\u201351.","journal-title":"Brain"},{"key":"529_CR61","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13024-023-00692-7","volume":"18","author":"P Yeapuri","year":"2023","unstructured":"Yeapuri P, Machhi J, Lu Y, Abdelmoaty MM, Kadry R, Patel M, et al. Amyloid-\u03b2 specific regulatory T cells attenuate alzheimer\u2019s disease pathobiology in APP\/PS1 mice. Mol Neurodegener. 2023;18:97.","journal-title":"Mol Neurodegener"},{"key":"529_CR62","doi-asserted-by":"publisher","first-page":"977","DOI":"10.3233\/JAD-221230","volume":"94","author":"N Ort\u00ed-Casa\u00f1","year":"2023","unstructured":"Ort\u00ed-Casa\u00f1 N, Wajant H, Kuiperij HB, Hooijsma A, Tromp L, Poortman IL, et al. Activation of TNF receptor 2 improves synaptic plasticity and enhances Amyloid-\u03b2 clearance in an alzheimer\u2019s disease mouse model with humanized TNF receptor 2. J Alzheimers Dis. 2023;94:977\u201391.","journal-title":"J Alzheimers Dis"},{"key":"529_CR63","doi-asserted-by":"publisher","first-page":"e2201137119","DOI":"10.1073\/pnas.2201137119","volume":"119","author":"N Ort\u00ed-Casa\u00f1","year":"2022","unstructured":"Ort\u00ed-Casa\u00f1 N, Zuhorn IS, Naud\u00e9 PJW, Deyn PP, van De, Schaik PEM, Wajant H, et al. A TNF receptor 2 agonist ameliorates neuropathology and improves cognition in an alzheimer\u2019s disease mouse model. Proc Natl Acad Sci U S A. 2022;119:e2201137119.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"529_CR64","doi-asserted-by":"publisher","first-page":"888274","DOI":"10.3389\/fimmu.2022.888274","volume":"13","author":"JG Vargas","year":"2022","unstructured":"Vargas JG, Wagner J, Shaikh H, Lang I, Medler J, Anany M, et al. A TNFR2-Specific TNF fusion protein with improved in vivo activity. Front Immunol. 2022;13:888274.","journal-title":"Front Immunol"},{"key":"529_CR65","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.immuni.2021.04.022","volume":"54","author":"L Shi","year":"2021","unstructured":"Shi L, Sun Z, Su W, Xu F, Xie D, Zhang Q, et al. Treg cell-derived osteopontin promotes microglia-mediated white matter repair after ischemic stroke. Immunity. 2021;54:1527\u201342.","journal-title":"Immunity"},{"key":"529_CR66","first-page":"1","volume":"14","author":"V Lamontain","year":"2018","unstructured":"Lamontain V, Schmid T, Weber-Steffens D, Zeller D, Jenei-Lanzl Z, Wajant H, et al. Stimulation of TNF receptor type 2 expands regulatory T cells and ameliorates established collagen-induced arthritis in mice. Cell Mol Immunol. 2018;14:1\u201310.","journal-title":"Cell Mol Immunol"},{"key":"529_CR67","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/stem.3320","volume":"39","author":"HW Caplan","year":"2021","unstructured":"Caplan HW, Prabhakara KS, Toledano Furman NE, Zorofchian S, Kumar A, Martin C, et al. Combination therapy with Treg and MSC enhances potency and Attenuation of inflammation after traumatic brain injury compared to monotherapy. Stem Cells. 2021;39:370.","journal-title":"Stem Cells"},{"key":"529_CR68","doi-asserted-by":"publisher","first-page":"17045","DOI":"10.1073\/pnas.1902091116","volume":"116","author":"R Fischer","year":"2019","unstructured":"Fischer R, Sendetski M, del Rivero T, Martinez GF, Bracchi-Ricard V, Swanson KA, et al. TNFR2 promotes Treg-mediated recovery from neuropathic pain across sexes. Proc Natl Acad Sci U S A. 2019;116:17045\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"529_CR69","doi-asserted-by":"crossref","unstructured":"Soto-Heredero G, Gaband\u00e9-Rodr\u00edguez E, Carrasco E, Escrig-Larena JI, de las G\u00f3mez MM, Delgado-Pulido S et al. KLRG1 identifies regulatory T cells with mitochondrial alterations that accumulate with aging. Nat Aging. 2025;17.","DOI":"10.1038\/s43587-025-00855-9"},{"key":"529_CR70","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.3389\/fimmu.2017.01064","volume":"8","author":"Y Zhao","year":"2017","unstructured":"Zhao Y, Cong L, Jaber V, Lukiw WJ. Microbiome-Derived lipopolysaccharide enriched in the perinuclear region of alzheimer\u2019s disease brain. Front Immunol. 2017;8:1064.","journal-title":"Front Immunol"},{"key":"529_CR71","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.it.2010.08.005","volume":"31","author":"JP McAleer","year":"2010","unstructured":"McAleer JP, Vella AT. Educating CD4 T cells with vaccine adjuvants: lessons from lipopolysaccharide. Trends Immunol. 2010;31:435.","journal-title":"Trends Immunol"},{"key":"529_CR72","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/j.1365-2567.2008.02832.x","volume":"125","author":"H Xu","year":"2008","unstructured":"Xu H, Liew LN, Kuo IC, Huang CH, Goh DLM, Chua KY. The modulatory effects of lipopolysaccharide-stimulated B cells on differential T-cell polarization. Immunology. 2008;125:218\u201328.","journal-title":"Immunology"},{"key":"529_CR73","doi-asserted-by":"publisher","first-page":"4221","DOI":"10.4049\/jimmunol.1302569","volume":"192","author":"W Cui","year":"2014","unstructured":"Cui W, Joshi NS, Liu Y, Meng H, Kleinstein SH, Kaech SM. TLR4 ligands lipopolysaccharide and monophosphoryl lipid a differentially regulate effector and memory CD8 + T cell differentiation. J Immunol. 2014;192:4221\u201332.","journal-title":"J Immunol"},{"key":"529_CR74","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.chom.2012.09.009","volume":"12","author":"II Ivanov","year":"2012","unstructured":"Ivanov II, Honda K. Intestinal commensal microbes as immune modulators. Cell Host Microbe. 2012;12:496\u2013508.","journal-title":"Cell Host Microbe"},{"key":"529_CR75","doi-asserted-by":"publisher","first-page":"19089","DOI":"10.18632\/oncotarget.7862","volume":"7","author":"H Li","year":"2016","unstructured":"Li H, Guo Z, Guo Y, Li M, Yan H, Cheng J, et al. Common DNA methylation alterations of alzheimer\u2019s disease and aging in peripheral whole blood. Oncotarget. 2016;7:19089\u201398.","journal-title":"Oncotarget"},{"key":"529_CR76","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3389\/fnagi.2015.00061","volume":"7","author":"J Song","year":"2015","unstructured":"Song J, Lee JE. miR-155 is involved in alzheimer\u2019s disease by regulating T lymphocyte function. Front Aging Neurosci. 2015;7:61.","journal-title":"Front Aging Neurosci"},{"key":"529_CR77","first-page":"136","volume":"8","author":"AR Naqvi","year":"2016","unstructured":"Naqvi AR, Zhong S, Dang H, Fordham JB, Nares S, Khan A. Expression profiling of LPS responsive MiRNA in primary human macrophages. J Microb Biochem Technol. 2016;8:136\u201343.","journal-title":"J Microb Biochem Technol"},{"key":"529_CR78","doi-asserted-by":"publisher","first-page":"5239","DOI":"10.1007\/s12035-021-02477-9","volume":"58","author":"B Kulkarni","year":"2021","unstructured":"Kulkarni B, Kumar D, Cruz-Martins N, Sellamuthu S. Role of TREM2 in alzheimer\u2019s disease: A long road ahead. Mol Neurobiol. 2021;58:5239\u201352.","journal-title":"Mol Neurobiol"},{"key":"529_CR79","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.cell.2020.05.003","volume":"181","author":"A Deczkowska","year":"2020","unstructured":"Deczkowska A, Weiner A, Amit I. The physiology, pathology, and potential therapeutic applications of the TREM2 signaling pathway. Cell. 2020;181:1207\u201317.","journal-title":"Cell"},{"key":"529_CR80","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.neuron.2016.05.003","volume":"90","author":"P Yuan","year":"2016","unstructured":"Yuan P, Condello C, Keene CD, Wang Y, Bird TD, Paul SM, et al. TREM2 haplodeficiency in mice and humans impairs the microglia barrier function leading to decreased amyloid compaction and severe axonal dystrophy. Neuron. 2016;90:724\u201339.","journal-title":"Neuron"},{"key":"529_CR81","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.neurobiolaging.2013.02.016","volume":"34","author":"M Giraldo","year":"2013","unstructured":"Giraldo M, Lopera F, Siniard AL, Corneveaux JJ, Schrauwen I, Carvajal J, et al. Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal Lobar degeneration and alzheimer\u2019s disease. Neurobiol Aging. 2013;34:10.","journal-title":"Neurobiol Aging"},{"key":"529_CR82","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fnagi.2017.00008","volume":"9","author":"M Brendel","year":"2017","unstructured":"Brendel M, Kleinberger G, Probst F, Jaworska A, Overhoff F, Blume T, et al. Increase of TREM2 during aging of an alzheimer\u2019s disease mouse model is paralleled by microglial activation and amyloidosis. Front Aging Neurosci. 2017;9:8.","journal-title":"Front Aging Neurosci"},{"key":"529_CR83","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/eji.201141679","volume":"42","author":"H Ito","year":"2012","unstructured":"Ito H, Hamerman JA. TREM-2, triggering receptor expressed on myeloid cell-2, negatively regulates TLR responses in dendritic cells. Eur J Immunol. 2012;42:176\u201385.","journal-title":"Eur J Immunol"},{"key":"529_CR84","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3233\/JAD-161277","volume":"58","author":"YJ Tan","year":"2017","unstructured":"Tan YJ, Ng ASL, Vipin A, Lim JKW, Chander RJ, Ji F, et al. Higher peripheral TREM2 mRNA levels relate to cognitive deficits and hippocampal atrophy in alzheimer\u2019s disease and amnestic mild cognitive impairment. J Alzheimer\u2019s Disease. 2017;58:413\u201323.","journal-title":"J Alzheimer\u2019s Disease"},{"key":"529_CR85","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jneumeth.2014.03.002","volume":"228","author":"J Labus","year":"2014","unstructured":"Labus J, H\u00e4ckel S, Lucka L, Danker K. Interleukin-1\u03b2 induces an inflammatory response and the breakdown of the endothelial cell layer in an improved human THBMEC-based in vitro blood\u2013brain barrier model. J Neurosci Methods. 2014;228:35\u201345.","journal-title":"J Neurosci Methods"},{"key":"529_CR86","doi-asserted-by":"publisher","first-page":"4376","DOI":"10.1096\/fj.201801595RR","volume":"33","author":"S Tan","year":"2019","unstructured":"Tan S, Shan Y, Lin Y, Liao S, Zhang B, Zeng Q, et al. Neutralization of interleukin-9 ameliorates experimental stroke by repairing the blood-brain barrier via down-regulation of astrocyte-derived vascular endothelial growth factor-A. FASEB J. 2019;33:4376\u201387.","journal-title":"FASEB J"},{"key":"529_CR87","doi-asserted-by":"publisher","first-page":"3856","DOI":"10.3390\/ijms19123856","volume":"19","author":"I Presta","year":"2018","unstructured":"Presta I, Vismara M, Novellino F, Donato A, Zaffino P, Scali E, et al. Innate immunity cells and the neurovascular unit. Int J Mol Sci. 2018;19:3856.","journal-title":"Int J Mol Sci"},{"key":"529_CR88","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/cns.13569","volume":"27","author":"X Huang","year":"2021","unstructured":"Huang X, Hussain B, Chang J. Peripheral inflammation and blood-brain barrier disruption: effects and mechanisms. CNS Neurosci Ther. 2021;27:36\u201347.","journal-title":"CNS Neurosci Ther"},{"key":"529_CR89","doi-asserted-by":"publisher","first-page":"631770","DOI":"10.3389\/fnagi.2021.631770","volume":"13","author":"JA Santiago","year":"2021","unstructured":"Santiago JA, Potashkin JA. The impact of disease comorbidities in alzheimer\u2019s disease. Front Aging Neurosci. 2021;13:631770.","journal-title":"Front Aging Neurosci"},{"key":"529_CR90","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12955-018-1018-4","volume":"16","author":"MM Husky","year":"2018","unstructured":"Husky MM, Ferdous Farin F, Compagnone P, Fermanian C, Kovess-Masfety V. Chronic back pain and its association with quality of life in a large French population survey. Health Qual Life Outcomes. 2018;16:195.","journal-title":"Health Qual Life Outcomes"},{"key":"529_CR91","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-019-1608-z","volume":"16","author":"S Cao","year":"2019","unstructured":"Cao S, Fisher DW, Yu T, Dong H. The link between chronic pain and alzheimer\u2019s disease. J Neuroinflamm. 2019;16:1\u201311.","journal-title":"J Neuroinflamm"},{"key":"529_CR92","doi-asserted-by":"publisher","first-page":"114287","DOI":"10.1016\/j.expneurol.2022.114287","volume":"360","author":"H Blanton","year":"2023","unstructured":"Blanton H, Reddy PH, Benamar K. Chronic pain in alzheimer\u2019s disease: endocannabinoid system. Exp Neurol. 2023;360:114287.","journal-title":"Exp Neurol"},{"key":"529_CR93","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1080\/03009742.2016.1218543","volume":"46","author":"C Larsson","year":"2017","unstructured":"Larsson C, Hansson EE, Sundquist K, Jakobsson U. Chronic pain in older adults: prevalence, incidence, and risk factors. Scand J Rheumatol. 2017;46:317\u201325.","journal-title":"Scand J Rheumatol"},{"key":"529_CR94","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1159\/000444791","volume":"41","author":"J Van Kooten","year":"2016","unstructured":"Van Kooten J, Van Der Binnekade TT, Stek ML, Scherder EJA, Huseb\u00f8 BS, et al. A review of pain prevalence in alzheimer\u2019s, vascular, frontotemporal and lewy body dementias. Dement Geriatr Cogn Disord. 2016;41:220\u201332.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"529_CR95","first-page":"1","volume":"5","author":"SW Huang","year":"2015","unstructured":"Huang SW, Wang W, Te, Chou LC, Liao C, De, Liou TH, Lin HW. Osteoarthritis increases the risk of dementia: A nationwide cohort study in Taiwan. Sci Rep. 2015;5:1\u20137.","journal-title":"Sci Rep"},{"key":"529_CR96","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1001\/jamainternmed.2017.1622","volume":"177","author":"EL Whitlock","year":"2017","unstructured":"Whitlock EL, Diaz-Ramirez LG, Glymour MM, Boscardin WJ, Covinsky KE, Smith AK. Association between persistent pain and memory decline and dementia in a longitudinal cohort of elders. JAMA Intern Med. 2017;177:1146.","journal-title":"JAMA Intern Med"},{"key":"529_CR97","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.amjms.2017.09.002","volume":"355","author":"NS Tzeng","year":"2018","unstructured":"Tzeng NS, Chung CH, Liu FC, Chiu YH, Chang HA, Yeh C, Bin, et al. Fibromyalgia and risk of Dementia\u2014A nationwide, Population-Based, cohort study. Am J Med Sci. 2018;355:153\u201361.","journal-title":"Am J Med Sci"},{"key":"529_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-023-02875-x","volume":"21","author":"J Tian","year":"2023","unstructured":"Tian J, Jones G, Lin X, Zhou Y, King A, Vickers J, et al. Association between chronic pain and risk of incident dementia: findings from a prospective cohort. BMC Med. 2023;21:1\u201313.","journal-title":"BMC Med"},{"key":"529_CR99","doi-asserted-by":"publisher","first-page":"e2215192120","DOI":"10.1073\/pnas.2215192120","volume":"120","author":"W Zhao","year":"2023","unstructured":"Zhao W, Zhao L, Chang X, Lu X, Tu Y. Elevated dementia risk, cognitive decline, and hippocampal atrophy in multisite chronic pain. Proc Natl Acad Sci U S A. 2023;120:e2215192120.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"529_CR100","doi-asserted-by":"publisher","first-page":"737874","DOI":"10.3389\/fnins.2021.737874","volume":"15","author":"X Zhang","year":"2021","unstructured":"Zhang X, Gao R, Zhang C, Chen H, Wang R, Zhao Q, et al. Evidence for cognitive decline in chronic pain: A systematic review and Meta-Analysis. Front Neurosci. 2021;15:737874.","journal-title":"Front Neurosci"},{"key":"529_CR101","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/ejp.1304","volume":"23","author":"D Kang","year":"2019","unstructured":"Kang D, McAuley JH, Kassem MS, Gatt JM, Gustin SM. What does the grey matter decrease in the medial prefrontal cortex reflect in people with chronic pain? Eur J Pain. 2019;23:203\u201319.","journal-title":"Eur J Pain"},{"key":"529_CR102","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/nm.4397","volume":"23","author":"MW Salter","year":"2017","unstructured":"Salter MW, Stevens B. Microglia emerge as central players in brain disease. Nat Med. 2017;23:1018\u201327.","journal-title":"Nat Med"},{"key":"529_CR103","doi-asserted-by":"publisher","first-page":"10410","DOI":"10.1523\/JNEUROSCI.2541-04.2004","volume":"24","author":"AV Apkarian","year":"2004","unstructured":"Apkarian AV, Sosa Y, Sonty S, Levy RM, Harden RN, Parrish TB, et al. Chronic back pain is associated with decreased prefrontal and thalamic Gray matter density. J Neurosci. 2004;24:10410.","journal-title":"J Neurosci"},{"key":"529_CR104","doi-asserted-by":"publisher","first-page":"5747","DOI":"10.1523\/JNEUROSCI.0587-12.2012","volume":"32","author":"AA Mutso","year":"2012","unstructured":"Mutso AA, Radzicki D, Baliki MN, Huang L, Banisadr G, Centeno MV, et al. Abnormalities in hippocampal functioning with persistent pain. J Neurosci. 2012;32:5747.","journal-title":"J Neurosci"},{"key":"529_CR105","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/s41591-020-0939-8","volume":"26","author":"S Alivernini","year":"2020","unstructured":"Alivernini S, MacDonald L, Elmesmari A, Finlay S, Tolusso B, Gigante MR, et al. Distinct synovial tissue macrophage subsets regulate inflammation and remission in rheumatoid arthritis. Nat Med. 2020;26:1295\u2013306.","journal-title":"Nat Med"},{"key":"529_CR106","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1515\/sjpain-2018-0340","volume":"19","author":"EB Hysing","year":"2019","unstructured":"Hysing EB, Smith L, Thulin M, Karlsten R, Bothelius K, Gordh T. Detection of systemic inflammation in severely impaired chronic pain patients and effects of a multimodal pain rehabilitation program. Scand J Pain. 2019;19:235\u201344.","journal-title":"Scand J Pain"},{"key":"529_CR107","doi-asserted-by":"publisher","first-page":"515","DOI":"10.2147\/JPR.S128508","volume":"10","author":"E B\u00e4ckryd","year":"2017","unstructured":"B\u00e4ckryd E, Tanum L, Lind AL, Larsson A, Gordh T. Evidence of both systemic inflammation and neuroinflammation in fibromyalgia patients, as assessed by a multiplex protein panel applied to the cerebrospinal fluid and to plasma. J Pain Res. 2017;10:515\u201325.","journal-title":"J Pain Res"},{"key":"529_CR108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/17448069231178176","volume":"19","author":"XX Fang","year":"2023","unstructured":"Fang XX, Zhai MN, Zhu M, He C, Wang H, Wang J, et al. Inflammation in pathogenesis of chronic pain: foe and friend. Mol Pain. 2023;19:1\u201315.","journal-title":"Mol Pain"},{"key":"529_CR109","doi-asserted-by":"publisher","first-page":"785214","DOI":"10.3389\/fnmol.2021.785214","volume":"14","author":"WBS Zhou","year":"2021","unstructured":"Zhou WBS, Meng JW, Zhang J. Does low grade systemic inflammation have a role in chronic pain?? Front Mol Neurosci. 2021;14:785214.","journal-title":"Front Mol Neurosci"},{"key":"529_CR110","doi-asserted-by":"publisher","first-page":"e84159","DOI":"10.1371\/journal.pone.0084159","volume":"8","author":"M De Goeij","year":"2013","unstructured":"De Goeij M, Van Eijk LT, Vanelderen P, Wilder-Smith OH, Van Der Vissers KC, et al. Systemic inflammation decreases pain threshold in humans in vivo. PLoS ONE. 2013;8:e84159.","journal-title":"PLoS ONE"},{"key":"529_CR111","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1097\/ACO.0b013e32833c348b","volume":"23","author":"D Yarnitsky","year":"2010","unstructured":"Yarnitsky D. Conditioned pain modulation (the diffuse noxious inhibitory control-like effect): its relevance for acute and chronic pain States. Curr Opin Anaesthesiol. 2010;23:611\u20135.","journal-title":"Curr Opin Anaesthesiol"},{"key":"529_CR112","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.bbi.2016.04.001","volume":"57","author":"B Karshikoff","year":"2016","unstructured":"Karshikoff B, Jensen KB, Kosek E, Kalpouzos G, Soop A, Ingvar M, et al. Why sickness hurts: A central mechanism for pain induced by peripheral inflammation. Brain Behav Immun. 2016;57:38\u201346.","journal-title":"Brain Behav Immun"},{"key":"529_CR113","doi-asserted-by":"publisher","first-page":"903455","DOI":"10.3389\/fnagi.2022.903455","volume":"14","author":"Y Sun","year":"2022","unstructured":"Sun Y, Koyama Y, Shimada S. Inflammation from peripheral organs to the brain: how does systemic inflammation cause neuroinflammation?? Front Aging Neurosci. 2022;14:903455.","journal-title":"Front Aging Neurosci"},{"key":"529_CR114","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.neuron.2018.11.009","volume":"100","author":"G Chen","year":"2018","unstructured":"Chen G, Zhang YQ, Qadri YJ, Serhan CN, Ji RR. Microglia in pain: detrimental and protective roles in pathogenesis and resolution of pain. Neuron. 2018;100:1292.","journal-title":"Neuron"},{"key":"529_CR115","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/ALN.0000000000002130","volume":"129","author":"RR Ji","year":"2018","unstructured":"Ji RR, Nackley A, Huh Y, Terrando N, Maixner W. Neuroinflammation and central sensitization in chronic and widespread pain. Anesthesiology. 2018;129:343.","journal-title":"Anesthesiology"},{"key":"529_CR116","doi-asserted-by":"publisher","first-page":"821534","DOI":"10.3389\/fphar.2021.821534","volume":"12","author":"F De Logu","year":"2021","unstructured":"De Logu F, Boccella S, Guida F, Editorial. The role of neuroinflammation in chronic pain development and maintenance. Front Pharmacol. 2021;12:821534.","journal-title":"Front Pharmacol"},{"key":"529_CR117","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1523\/JNEUROSCI.2235-16.2016","volume":"37","author":"Y Liu","year":"2017","unstructured":"Liu Y, Zhou LJ, Wang J, Li D, Ren WJ, Peng J, et al. TNF-\u03b1 differentially regulates synaptic plasticity in the Hippocampus and spinal cord by Microglia-Dependent mechanisms after peripheral nerve injury. J Neurosci. 2017;37:871.","journal-title":"J Neurosci"},{"key":"529_CR118","doi-asserted-by":"publisher","first-page":"e20191430","DOI":"10.1084\/jem.20191430","volume":"217","author":"B Mailhot","year":"2020","unstructured":"Mailhot B, Christin M, Tessandier N, Sotoudeh C, Bretheau F, Turmel R, et al. Neuronal interleukin-1 receptors mediate pain in chronic inflammatory diseases. J Exp Med. 2020;217:e20191430.","journal-title":"J Exp Med"},{"key":"529_CR119","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3389\/fnins.2019.00213","volume":"13","author":"EE Barcelon","year":"2019","unstructured":"Barcelon EE, Cho WH, Jun SB, Lee SJ. Brain microglial activation in chronic pain-associated affective disorder. Front Neurosci. 2019;13:213.","journal-title":"Front Neurosci"},{"key":"529_CR120","doi-asserted-by":"publisher","first-page":"12468","DOI":"10.1073\/pnas.1511003112","volume":"112","author":"CM Sandiego","year":"2015","unstructured":"Sandiego CM, Gallezot JD, Pittman B, Nabulsi N, Lim K, Lin SF, et al. Imaging robust microglial activation after lipopolysaccharide administration in humans with PET. Proc Natl Acad Sci U S A. 2015;112:12468.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"529_CR121","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1093\/brain\/aww016","volume":"139","author":"EE Spangenberg","year":"2016","unstructured":"Spangenberg EE, Lee RJ, Najafi AR, Rice RA, Elmore MRP, Blurton-Jones M, et al. Eliminating microglia in alzheimer\u2019s mice prevents neuronal loss without modulating amyloid-\u03b2 pathology. Brain. 2016;139:1265\u201381.","journal-title":"Brain"},{"key":"529_CR122","doi-asserted-by":"publisher","first-page":"107087","DOI":"10.1016\/j.cct.2023.107087","volume":"126","author":"EJ Morrissey","year":"2023","unstructured":"Morrissey EJ, Alshelh Z, Knight PC, Saha A, Kim M, Torrado-Carvajal A, et al. Assessing the potential Anti-Neuroinflammatory effect of Minocycline in chronic low back pain: protocol for a randomized, double-blind, placebo-controlled trial. Contemp Clin Trials. 2023;126:107087.","journal-title":"Contemp Clin Trials"},{"key":"529_CR123","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2147\/JPR.S292824","volume":"14","author":"DA Shin","year":"2021","unstructured":"Shin DA, Kim TU, Chang MC. Minocycline for controlling neuropathic pain: A systematic narrative review of studies in humans. J Pain Res. 2021;14:139\u201345.","journal-title":"J Pain Res"},{"key":"529_CR124","doi-asserted-by":"publisher","first-page":"702","DOI":"10.4103\/1673-5374.206633","volume":"12","author":"RB Shultz","year":"2017","unstructured":"Shultz RB, Zhong Y. Minocycline targets multiple secondary injury mechanisms in traumatic spinal cord injury. Neural Regen Res. 2017;12:702\u201313.","journal-title":"Neural Regen Res"},{"key":"529_CR125","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1080\/01616412.2023.2296754","volume":"46","author":"EY Abdo Qaid","year":"2024","unstructured":"Abdo Qaid EY, Abdullah Z, Zakaria R, Long I. Minocycline mitigates Tau pathology via modulating the TLR-4\/NF-\u043a\u03b2 signalling pathway in the hippocampus of neuroinflammation rat model. Neurol Res. 2024;46:261\u201371.","journal-title":"Neurol Res"},{"key":"529_CR126","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.2174\/1570159X19666211202124925","volume":"20","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Wang C, He W, Cai Z. Ameliorating Alzheimer\u2019s-like pathology by Minocycline via inhibiting Cdk5\/p25 signaling. Curr Neuropharmacol. 2022;20:1783\u201392.","journal-title":"Curr Neuropharmacol"},{"key":"529_CR127","doi-asserted-by":"publisher","first-page":"102158","DOI":"10.1016\/j.jchemneu.2022.102158","volume":"125","author":"Z Gholami Mahmoudian","year":"2022","unstructured":"Gholami Mahmoudian Z, komaki A, Rashidi I, Amiri I, Ghanbari A. The effect of Minocycline on beta-amyloid-induced memory and learning deficit in male rats: A behavioral, biochemical, and histological study. J Chem Neuroanat. 2022;125:102158.","journal-title":"J Chem Neuroanat"},{"key":"529_CR128","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1038\/sj.npp.1301377","volume":"32","author":"Y Choi","year":"2007","unstructured":"Choi Y, Kim HS, Shin KY, Kim EM, Kim M, Kim HS, et al. Minocycline attenuates neuronal cell death and improves cognitive impairment in alzheimer\u2019s disease models. Neuropsychopharmacology. 2007;32:2393\u2013404.","journal-title":"Neuropsychopharmacology"},{"key":"529_CR129","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1159\/000330363","volume":"9","author":"B Biscaro","year":"2012","unstructured":"Biscaro B, Lindvall O, Tesco G, Ekdahl CT, Nitsch RM. Inhibition of microglial activation protects hippocampal neurogenesis and improves cognitive deficits in a Transgenic mouse model for alzheimer\u2019s disease. Neurodegener Dis. 2012;9:187\u201398.","journal-title":"Neurodegener Dis"},{"key":"529_CR130","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.2147\/CIA.S46536","volume":"8","author":"Z Cai","year":"2013","unstructured":"Cai Z, Yan Y, Wang Y. Clinical interventions in aging Dovepress Minocycline alleviates beta-amyloid protein and Tau pathology via restraining neuroinflammation induced by diabetic metabolic disorder. Clin Interv Aging. 2013;8:1089\u201395.","journal-title":"Clin Interv Aging"},{"key":"529_CR131","doi-asserted-by":"publisher","first-page":"175784","DOI":"10.1016\/j.ejphar.2023.175784","volume":"953","author":"Z Gholami Mahmoudian","year":"2023","unstructured":"Gholami Mahmoudian Z, Ghanbari A, Rashidi I, Amiri I, Komaki A. Minocycline effects on memory and learning impairment in the beta-amyloid-induced alzheimer\u2019s disease model in male rats using behavioral, biochemical, and histological methods. Eur J Pharmacol. 2023;953:175784.","journal-title":"Eur J Pharmacol"},{"key":"529_CR132","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1001\/jamaneurol.2019.3762","volume":"77","author":"R Howard","year":"2020","unstructured":"Howard R, Zubko O, Bradley R, Harper E, Pank L, O\u2019Brien J, et al. Minocycline at 2 different dosages vs placebo for patients with mild alzheimer disease: A randomized clinical trial. JAMA Neurol. 2020;77:164\u201374.","journal-title":"JAMA Neurol"},{"key":"529_CR133","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4110\/in.2012.12.2.41","volume":"12","author":"MK Jha","year":"2012","unstructured":"Jha MK, Jeon S, Suk K. Glia as a link between neuroinflammation and neuropathic pain. Immune Netw. 2012;12:41\u20137.","journal-title":"Immune Netw"},{"key":"529_CR134","doi-asserted-by":"publisher","first-page":"11138","DOI":"10.1523\/JNEUROSCI.1238-16.2016","volume":"36","author":"M Kobayashi","year":"2016","unstructured":"Kobayashi M, Konishi H, Sayo A, Takai T, Kiyama H. TREM2\/DAP12 signal elicits Proinflammatory response in microglia and exacerbates neuropathic pain. J Neurosci. 2016;36:11138\u201350.","journal-title":"J Neurosci"},{"key":"529_CR135","doi-asserted-by":"publisher","first-page":"894963","DOI":"10.3389\/fphar.2022.894963","volume":"13","author":"L Zhang","year":"2022","unstructured":"Zhang L, Li N, Zhang H, Wang Y, Gao T, Zhao Y, et al. Artesunate therapy alleviates Fracture-Associated chronic pain after orthopedic surgery by suppressing CCL21-Dependent TREM2\/DAP12 inflammatory signaling in mice. Front Pharmacol. 2022;13:894963.","journal-title":"Front Pharmacol"},{"key":"529_CR136","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s40200-019-00411-4","volume":"18","author":"C Aishah","year":"2019","unstructured":"Aishah C, Ismail N, Suppian R, Badariah C, Aziz A, Long I. Minocycline attenuates the development of diabetic neuropathy by modulating DREAM and BDNF protein expression in rat spinal cord. J Diabetes Metabolic Disorders. 2019;18:181\u201390.","journal-title":"J Diabetes Metabolic Disorders"},{"key":"529_CR137","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.3892\/mmr.2015.3735","volume":"12","author":"JS Sun","year":"2015","unstructured":"Sun JS, Yang YJ, Zhang YZ, Huang W, Li ZS, Zhang Y. Minocycline attenuates pain by inhibiting spinal microglia activation in diabetic rats. Mol Med Rep. 2015;12:2677\u201382.","journal-title":"Mol Med Rep"},{"key":"529_CR138","doi-asserted-by":"publisher","first-page":"3577","DOI":"10.3390\/molecules26123577","volume":"26","author":"K Sa\u0142at","year":"2021","unstructured":"Sa\u0142at K, Furga\u0142a-Wojas A, Sa\u0142at R. The microglial activation inhibitor minocycline, used alone and in combination with duloxetine, attenuates pain caused by oxaliplatin in mice. Molecules. 2021;26:3577.","journal-title":"Molecules"},{"key":"529_CR139","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.jpain.2022.09.016","volume":"24","author":"T Vezza","year":"2023","unstructured":"Vezza T, Molina-Tijeras JA, Gonz\u00e1lez-Cano R, Rodr\u00edguez-Nogales A, Garc\u00eda F, G\u00e1lvez J, et al. Minocycline prevents the development of key features of inflammation and pain in DSS-induced colitis in mice. J Pain. 2023;24:304\u201319.","journal-title":"J Pain"},{"key":"529_CR140","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1744-8069-8-13","volume":"8","author":"IH Cho","year":"2012","unstructured":"Cho IH, Lee MJ, Jang M, Gwak NG, Lee KY, Jung HS. Minocycline markedly reduces acute visceral nociception via inhibiting neuronal ERK phosphorylation. Mol Pain. 2012;8:13.","journal-title":"Mol Pain"},{"key":"529_CR141","first-page":"3407","volume":"25","author":"DR Pachman","year":"2017","unstructured":"Pachman DR, Dockter T, Zekan PJ, Fruth B, Ruddy KJ, Ta LE, et al. A pilot study of Minocycline for the prevention of paclitaxel-associated neuropathy: ACCRU study RU221408I. Support Care Cancer. 2017;25:3407\u201316.","journal-title":"Support Care Cancer"},{"key":"529_CR142","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1002\/ejp.649","volume":"19","author":"RA Moore","year":"2015","unstructured":"Moore RA, Derry S, Wiffen PJ, Straube S, Aldington DJ. Overview review: comparative efficacy of oral ibuprofen and Paracetamol (acetaminophen) across acute and chronic pain conditions. Eur J Pain. 2015;19:1213\u201323.","journal-title":"Eur J Pain"},{"key":"529_CR143","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.brainres.2008.01.095","volume":"1207","author":"AC McKee","year":"2008","unstructured":"McKee AC, Carreras I, Hossain L, Ryu H, Klein WL, Oddo S, et al. Ibuprofen reduces A\u03b2, hyperphosphorylated Tau and memory deficits in alzheimer mice. Brain Res. 2008;1207:225.","journal-title":"Brain Res"},{"key":"529_CR144","doi-asserted-by":"publisher","first-page":"5709","DOI":"10.1523\/JNEUROSCI.20-15-05709.2000","volume":"20","author":"GP Lim","year":"2000","unstructured":"Lim GP, Yang F, Chu T, Chen P, Beech W, Teter B, et al. Ibuprofen suppresses plaque pathology and inflammation in a mouse model for alzheimer\u2019s disease. J Neurosci. 2000;20:5709.","journal-title":"J Neurosci"},{"key":"529_CR145","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2967\/jnumed.111.094029","volume":"53","author":"AL Brownell","year":"2012","unstructured":"Brownell AL, Jokivarsi K, Dedeoglu A. Ibuprofen reduces inflammatory response in alzheimer mice. J Nucl Med. 2012;53:415\u2013415.","journal-title":"J Nucl Med"},{"key":"529_CR146","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1177\/0269881108097630","volume":"24","author":"D Van Dam","year":"2008","unstructured":"Van Dam D, Coen K, De Deyn PP. Ibuprofen modifies cognitive disease progression in an alzheimer\u2019s mouse model. Psychopharm. 2008;24:383\u20138.","journal-title":"Psychopharm"},{"key":"529_CR147","doi-asserted-by":"crossref","unstructured":"\u2019t Veld BA, Ruitenberg A, Hofman A, Launer LJ, van Duijn CM, Stijnen T Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer\u2019s Disease, et al. editors. New England Journal of Medicine. 2001;345:1515\u201321.","DOI":"10.1056\/NEJMoa010178"},{"key":"529_CR148","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/0197-4580(95)00049-K","volume":"16","author":"JCS Breitner","year":"1995","unstructured":"Breitner JCS, Welsh KA, Helms MJ, Gaskell PC, Gau BA, Roses AD, et al. Delayed onset of alzheimer\u2019s disease with nonsteroidal anti-inflammatory and Histamine H2 blocking drugs. Neurobiol Aging. 1995;16:523\u201330.","journal-title":"Neurobiol Aging"},{"key":"529_CR149","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3389\/fnagi.2018.00083","volume":"10","author":"C Zhang","year":"2018","unstructured":"Zhang C, Wang Y, Wang D, Zhang J, Zhang F. NSAID exposure and risk of alzheimer\u2019s disease: an updated meta-analysis from cohort studies. Front Aging Neurosci. 2018;10:83.","journal-title":"Front Aging Neurosci"},{"key":"529_CR150","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1212\/01.wnl.0000311269.57716.63","volume":"70","author":"SC Vlad","year":"2008","unstructured":"Vlad SC, Miller DR, Kowall NW, Felson DT. Protective effects of NSAIDs on the development of alzheimer disease. Neurology. 2008;70:1672\u20137.","journal-title":"Neurology"},{"key":"529_CR151","first-page":"275","volume":"69","author":"K Hayden","year":"2007","unstructured":"Hayden K, Zandi P, Khachaturian A, Szekely C, Fotuhi M, Norton M, et al. Does NSAID use modify cognitive trajectories in the elderly? Cache Cty Study. 2007;69:275\u201382.","journal-title":"Cache Cty Study"},{"key":"529_CR152","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1212\/WNL.0b013e3181a18691","volume":"72","author":"JCS Breitner","year":"2009","unstructured":"Breitner JCS, Haneuse SJPA, Walker R, Dublin S, Crane PK, Gray SL, et al. Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort. Neurology. 2009;72:1899\u2013905.","journal-title":"Neurology"},{"key":"529_CR153","first-page":"1555","volume":"2","author":"M Sastre","year":"2010","unstructured":"Sastre M, Gentleman SM, NSAIDs. How they work and their prospects as therapeutics in alzheimer\u2019s disease. Front Aging Neurosci. 2010;2:1555.","journal-title":"Front Aging Neurosci"},{"key":"529_CR154","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.jpsychires.2023.11.030","volume":"169","author":"S Yuan","year":"2024","unstructured":"Yuan S, Ling Y, Huang X, Tan S, Li W, Xu A, et al. Associations between the use of common nonsteroidal anti-inflammatory drugs, genetic susceptibility and dementia in participants with chronic pain: A prospective study based on 194,758 participants from the UK biobank. J Psychiatr Res. 2024;169:152\u20139.","journal-title":"J Psychiatr Res"},{"key":"529_CR155","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.genhosppsych.2023.08.006","volume":"84","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Zhou C, Yang S, Zhang Y, Ye Z, He P, et al. Association of regular use of ibuprofen and paracetamol, genetic susceptibility, and new-onset dementia in the older population. Gen Hosp Psychiatry. 2023;84:226\u201333.","journal-title":"Gen Hosp Psychiatry"},{"key":"529_CR156","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/ibra.12023","volume":"8","author":"YH Guan","year":"2022","unstructured":"Guan YH, Zhang LJ, Wang SY, Deng YD, Zhou HS, Chen DQ, et al. The role of microglia in alzheimer\u2019s disease and progress of treatment. Ibrain. 2022;8:37\u201347.","journal-title":"Ibrain"},{"key":"529_CR157","doi-asserted-by":"publisher","first-page":"5150678","DOI":"10.1155\/2017\/5150678","volume":"2017","author":"J Yin","year":"2017","unstructured":"Yin J, Valin KL, Dixon ML, Leavenworth JW. The role of microglia and macrophages in CNS homeostasis, autoimmunity, and Cancer. J Immunol Res. 2017;2017:5150678.","journal-title":"J Immunol Res"},{"key":"529_CR158","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-017-0216-6","volume":"12","author":"SM Bemiller","year":"2017","unstructured":"Bemiller SM, McCray TJ, Allan K, Formica SV, Xu G, Wilson G, et al. TREM2 deficiency exacerbates Tau pathology through dysregulated kinase signaling in a mouse model of Tauopathy. Mol Neurodegener. 2017;12:1\u201312.","journal-title":"Mol Neurodegener"},{"key":"529_CR159","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/s41593-019-0433-0","volume":"22","author":"CEG Leyns","year":"2019","unstructured":"Leyns CEG, Gratuze M, Narasimhan S, Jain N, Koscal LJ, Jiang H, et al. TREM2 function impedes Tau seeding in neuritic plaques. Nat Neurosci. 2019;22:1217\u201322.","journal-title":"Nat Neurosci"},{"key":"529_CR160","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R, et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity. 2017;47:566\u201381.","journal-title":"Immunity"},{"key":"529_CR161","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s10072-011-0599-z","volume":"32","author":"P Andrade","year":"2011","unstructured":"Andrade P, Visser-Vandewalle V, Hoffmann C, Steinbusch HWM, Daemen MA, Hoogland G. Role of TNF-alpha during central sensitization in preclinical studies. Neurol Sci. 2011;32:757\u201371.","journal-title":"Neurol Sci"},{"key":"529_CR162","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1742-2094-7-27","volume":"7","author":"L Leung","year":"2010","unstructured":"Leung L, Cahill CM. TNF-\u03b1 and neuropathic pain - a review. J Neuroinflammation. 2010;7:27.","journal-title":"J Neuroinflammation"},{"key":"529_CR163","doi-asserted-by":"publisher","first-page":"780876","DOI":"10.3389\/fneur.2021.780876","volume":"12","author":"AD Maguire","year":"2021","unstructured":"Maguire AD, Bethea JR, Kerr BJ. TNF\u03b1 in MS and its animal models: implications for chronic pain in the disease. Front Neurol. 2021;12:780876.","journal-title":"Front Neurol"},{"key":"529_CR164","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s00011-019-01286-0","volume":"68","author":"CM Ribeiro","year":"2019","unstructured":"Ribeiro CM, Oliveira SR, Alfieri DF, Flauzino T, Kaimen-Maciel DR, Sim\u00e3o ANC, et al. Tumor necrosis factor alpha (TNF-\u03b1) and its soluble receptors are associated with disability, disability progression and clinical forms of multiple sclerosis. Inflamm Res. 2019;68:1049\u201359.","journal-title":"Inflamm Res"},{"key":"529_CR165","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.ejpain.2008.08.001","volume":"13","author":"F Marchand","year":"2009","unstructured":"Marchand F, Tsantoulas C, Singh D, Grist J, Clark AK, Bradbury EJ, et al. Effects of etanercept and Minocycline in a rat model of spinal cord injury. Eur J Pain. 2009;13:673\u201381.","journal-title":"Eur J Pain"},{"key":"529_CR166","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1212\/WNL.53.3.444","volume":"53","author":"SR Schwid","year":"1999","unstructured":"Schwid SR, Noseworthy JH. Targeting immunotherapy in multiple sclerosis: A near hit and a clear miss. Neurology. 1999;53:444\u20135.","journal-title":"Neurology"},{"key":"529_CR167","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1097\/j.pain.0000000000001470","volume":"160","author":"T Del Rivero","year":"2019","unstructured":"Del Rivero T, Fischer R, Yang F, Swanson KA, Bethea JR. Tumor necrosis factor receptor 1 Inhibition is therapeutic for neuropathic pain in males but not in females. Pain. 2019;160:922\u201331.","journal-title":"Pain"},{"key":"529_CR168","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fnins.2019.00049","volume":"13","author":"N Ort\u00ed-Casa\u00f1","year":"2019","unstructured":"Ort\u00ed-Casa\u00f1 N, Wu Y, Naud\u00e9 PJW, De Deyn PP, Zuhorn IS, Eisel ULM. Targeting TNFR2 as a novel therapeutic strategy for alzheimer\u2019s disease. Front Neurosci. 2019;13:49.","journal-title":"Front Neurosci"},{"key":"529_CR169","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/anae.15896","volume":"78","author":"CR Bain","year":"2023","unstructured":"Bain CR, Myles PS, Corcoran T, Dieleman JM. Postoperative systemic inflammatory dysregulation and corticosteroids: a narrative review. Anaesthesia. 2023;78:356\u201370.","journal-title":"Anaesthesia"},{"key":"529_CR170","first-page":"349","volume":"19","author":"P Toft","year":"2008","unstructured":"Toft P, T\u00f8nnesen E. The systemic inflammatory response to anaesthesia and surgery. Curr Anaesth Crit Care. 2008;19:349\u201353.","journal-title":"Curr Anaesth Crit Care"},{"key":"529_CR171","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.sopen.2019.06.001","volume":"2","author":"A Alhayyan","year":"2020","unstructured":"Alhayyan A, McSorley S, Roxburgh C, Kearns R, Horgan P, McMillan D. The effect of anesthesia on the postoperative systemic inflammatory response in patients undergoing surgery: A systematic review and meta-analysis. Surg Open Sci. 2020;2:1\u201321.","journal-title":"Surg Open Sci"},{"key":"529_CR172","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1097\/EJA.0000000000000319","volume":"32","author":"D Fletcher","year":"2015","unstructured":"Fletcher D, Stamer UM, Pogatzki-Zahn E, Zaslansky R, Tanase NV, Perruchoud C, et al. Chronic postsurgical pain in europe: an observational study. Eur J Anaesthesiol. 2015;32:725\u201334.","journal-title":"Eur J Anaesthesiol"},{"key":"529_CR173","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/bja\/aeq323","volume":"105","author":"C Voscopoulos","year":"2010","unstructured":"Voscopoulos C, Lema M. When does acute pain become chronic? Br J Anaesth. 2010;105:69\u201385.","journal-title":"Br J Anaesth"},{"key":"529_CR174","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3233\/JAD-2005-7408","volume":"7","author":"TA Lee","year":"2016","unstructured":"Lee TA, Wolozin B, Weiss KB, Bednar MM. Assessment of the emergence of alzheimer\u2019s disease following coronary artery bypass graft surgery or percutaneous transluminal coronary angioplasty. J Alzheimer\u2019s Disease. 2016;7:319\u201324.","journal-title":"J Alzheimer\u2019s Disease"},{"issue":"Suppl 3","key":"529_CR175","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3233\/JAD-2010-100843","volume":"22","author":"T Vanderweyde","year":"2010","unstructured":"Vanderweyde T, Bednar MM, Forman SA, Wolozin B. Iatrogenic risk factors for alzheimer\u2019s disease: surgery and anesthesia. J Alzheimers Dis. 2010;22(Suppl 3):91\u2013104.","journal-title":"J Alzheimers Dis"},{"key":"529_CR176","first-page":"1","volume":"4","author":"Z Xu","year":"2014","unstructured":"Xu Z, Dong Y, Wang H, Culley DJ, Marcantonio ER, Crosby G, et al. Age-dependent postoperative cognitive impairment and Alzheimer-related neuropathology in mice. Sci Rep. 2014;4:1\u201310.","journal-title":"Sci Rep"},{"key":"529_CR177","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1097\/00000542-200703000-00007","volume":"106","author":"Y Wan","year":"2007","unstructured":"Wan Y, Xu J, Ma D, Zeng Y, Cibelli M, Maze M. Postoperative impairment of cognitive function in RatsA possible role for Cytokine-mediated inflammation in the Hippocampus. Anesthesiology. 2007;106:436\u201343.","journal-title":"Anesthesiology"},{"key":"529_CR178","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.neuro.2025.02.003","volume":"107","author":"Y Yang","year":"2025","unstructured":"Yang Y, Wang B, Jiang Y, Fu W. Tanshinone IIA mitigates postoperative cognitive dysfunction in aged rats by inhibiting hippocampal inflammation and ferroptosis: role of Nrf2\/SLC7A11\/GPX4 axis activation. Neurotoxicology. 2025;107:62\u201373.","journal-title":"Neurotoxicology"},{"key":"529_CR179","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.biopsych.2008.07.024","volume":"65","author":"C Cunningham","year":"2009","unstructured":"Cunningham C, Campion S, Lunnon K, Murray CL, Woods JFC, Deacon RMJ, et al. Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease. Biol Psychiatry. 2009;65:304\u201312.","journal-title":"Biol Psychiatry"},{"key":"529_CR180","doi-asserted-by":"publisher","first-page":"20518","DOI":"10.1073\/pnas.1014557107","volume":"107","author":"N Terrando","year":"2010","unstructured":"Terrando N, Monaco C, Ma D, Foxwell BMJ, Feldmannc M, Maze M. Tumor necrosis factor-a triggers a cytokine cascade yielding postoperative cognitive decline. Proc Natl Acad Sci U S A. 2010;107:20518\u201322.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"529_CR181","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1001\/jamaneurol.2021.2823","volume":"78","author":"I Feinstein","year":"2021","unstructured":"Feinstein I, Wilson EN, Swarovski MS, Andreasson KI, Angst MS, Greicius MD. Plasma biomarkers of Tau and neurodegeneration during major cardiac and noncardiac surgery. JAMA Neurol. 2021;78:1407\u20139.","journal-title":"JAMA Neurol"},{"key":"529_CR182","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13195-021-00802-x","volume":"13","author":"C Tissot","year":"2021","unstructured":"Tissot C, Benedet L, Therriault A, Pascoal J, Lussier TA, Saha-Chaudhuri FZ. Plasma pTau181 predicts cortical brain atrophy in aging and alzheimer\u2019s disease. Alzheimers Res Ther. 2021;13:1\u201311.","journal-title":"Alzheimers Res Ther"},{"key":"529_CR183","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/mco2.1","volume":"1","author":"J Meng","year":"2020","unstructured":"Meng J, Lei P. Plasma pTau181 as a biomarker for alzheimer\u2019s disease. MedComm (Beijing). 2020;1:74\u20136.","journal-title":"MedComm (Beijing)"},{"key":"529_CR184","doi-asserted-by":"publisher","first-page":"e0281049","DOI":"10.1371\/journal.pone.0281049","volume":"18","author":"S Sugita","year":"2023","unstructured":"Sugita S, Tahir P, Kinjo S. The effects of microbiome-targeted therapy on cognitive impairment and postoperative cognitive dysfunction\u2014A systematic review. PLoS ONE. 2023;18:e0281049.","journal-title":"PLoS ONE"},{"key":"529_CR185","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1213\/ANE.0000000000004053","volume":"128","author":"S Subramaniyan","year":"2019","unstructured":"Subramaniyan S, Terrando N. Neuroinflammation and perioperative neurocognitive disorders. Anesth Analg. 2019;128:781\u20138.","journal-title":"Anesth Analg"},{"key":"529_CR186","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.brainresbull.2020.08.017","volume":"164","author":"J Wen","year":"2020","unstructured":"Wen J, Ding Y, Wang L, Xiao Y. Gut Microbiome improves postoperative cognitive function by decreasing permeability of the blood-brain barrier in aged mice. Brain Res Bull. 2020;164:249\u201356.","journal-title":"Brain Res Bull"},{"key":"529_CR187","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.bbi.2019.05.006","volume":"80","author":"XL Jiang","year":"2019","unstructured":"Jiang XL, Gu XY, Zhou XX, Chen XM, Zhang X, Yang YT, et al. Intestinal dysbacteriosis mediates the reference memory deficit induced by anaesthesia\/surgery in aged mice. Brain Behav Immun. 2019;80:605\u201315.","journal-title":"Brain Behav Immun"},{"key":"529_CR188","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12871-018-0642-1","volume":"18","author":"XD Yang","year":"2018","unstructured":"Yang XD, Wang LK, Wu HY, Jiao L. Effects of prebiotic galacto-oligosaccharide on postoperative cognitive dysfunction and neuroinflammation through targeting of the gut-brain axis. BMC Anesthesiol. 2018;18:1\u201311.","journal-title":"BMC Anesthesiol"},{"key":"529_CR189","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3389\/fnagi.2017.00403","volume":"9","author":"D Chen","year":"2017","unstructured":"Chen D, Yang X, Yang J, Lai G, Yong T, Tang X, et al. Prebiotic effect of fructooligosaccharides from Morinda officinalis on alzheimer\u2019s disease in rodent models by targeting the microbiota-gut-brain axis. Front Aging Neurosci. 2017;9:403.","journal-title":"Front Aging Neurosci"},{"key":"529_CR190","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1038\/s41598-017-02587-2","volume":"7","author":"L Bonfili","year":"2017","unstructured":"Bonfili L, Cecarini V, Berardi S, Scarpona S, Suchodolski JS, Nasuti C, et al. Microbiota modulation counteracts alzheimer\u2019s disease progression influencing neuronal proteolysis and gut hormones plasma levels. Sci Rep. 2017;7:2426.","journal-title":"Sci Rep"},{"key":"529_CR191","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41422-019-0216-x","volume":"29","author":"X Wang","year":"2019","unstructured":"Wang X, Sun G, Feng T, Zhang J, Huang X, Wang T, et al. Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit alzheimer\u2019s disease progression. Cell Res. 2019;29:787\u2013803.","journal-title":"Cell Res"},{"key":"529_CR192","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/ana.22082","volume":"68","author":"M Cibelli","year":"2010","unstructured":"Cibelli M, Fidalgo AR, Terrando N, Ma D, Monaco C, Feldmann M, et al. Role of Interleukin-1\u03b2 in postoperative cognitive dysfunction. Ann Neurol. 2010;68:360\u20138.","journal-title":"Ann Neurol"},{"key":"529_CR193","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.clnu.2020.05.001","volume":"40","author":"P Wang","year":"2021","unstructured":"Wang P, Yin X, Chen G, Li L, Le Y, Xie Z, et al. Perioperative probiotic treatment decreased the incidence of postoperative cognitive impairment in elderly patients following non-cardiac surgery: A randomised double-blind and placebo-controlled trial. Clin Nutr. 2021;40:64\u201371.","journal-title":"Clin Nutr"},{"key":"529_CR194","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/ALN.0000000000004439","volume":"138","author":"T Takazawa","year":"2023","unstructured":"Takazawa T, Horiuchi T, Orihara M, Nagumo K, Tomioka A, Ideno Y, et al. Prevention of postoperative cognitive dysfunction by Minocycline in elderly patients after total knee arthroplasty: A randomized, Double-blind, Placebo-controlled clinical trial. Anesthesiology. 2023;138:172\u201383.","journal-title":"Anesthesiology"},{"key":"529_CR195","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-014-0217-0","volume":"11","author":"C Lim","year":"2014","unstructured":"Lim C, Hammond CJ, Hingley ST, Balin BJ. Chlamydia pneumoniae infection of monocytes in vitro stimulates innate and adaptive immune responses relevant to those in alzheimer\u2019s disease. J Neuroinflammation. 2014;11:1\u201311.","journal-title":"J Neuroinflammation"},{"key":"529_CR196","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.neuron.2022.12.029","volume":"111","author":"KS Levine","year":"2023","unstructured":"Levine KS, Leonard HL, Blauwendraat C, Iwaki H, Johnson N, Bandres-Ciga S, et al. Virus exposure and neurodegenerative disease risk across National biobanks. Neuron. 2023;111:1086\u201393.","journal-title":"Neuron"},{"key":"529_CR197","first-page":"2905","volume":"142","author":"F Panza","year":"2019","unstructured":"Panza F, Lozupone M, Solfrizzi V, Watling M, Imbimbo BP. Time to test antibacterial therapy in alzheimer\u2019s disease. Brain. 2019;142:2905\u201329.","journal-title":"Brain"},{"key":"529_CR198","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12934-021-01520-7","volume":"20","author":"D Vigasova","year":"2021","unstructured":"Vigasova D, Nemergut M, Liskova B, Damborsky J. Multi-pathogen infections and alzheimer\u2019s disease. Microb Cell Fact. 2021;20:1\u201313.","journal-title":"Microb Cell Fact"},{"issue":"5","key":"529_CR199","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1017\/S003329171200195X","volume":"43","author":"AMM Watson","year":"2013","unstructured":"Watson AMM, Prasad KM, Klei L, Wood JA, Yolken RH, Gur RC, et al. Persistent infection with neurotropic herpes viruses and cognitive impairment. Psychol Med. 2013;43(5):1023\u201331.","journal-title":"Psychol Med"},{"key":"529_CR200","doi-asserted-by":"crossref","unstructured":"Tzeng NS, Chung CH, Lin FH, Chiang CP, Yeh C, Bin, Huang SY et al. Anti-herpetic Medications and Reduced Risk of Dementia in Patients with Herpes Simplex Virus Infections-a Nationwide, Population-Based Cohort Study in Taiwan. Neurotherapeutics [Internet]. 2018 Apr 1 [cited 2023 Aug 15];15(2):417\u201329. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29488144\/","DOI":"10.1007\/s13311-018-0611-x"},{"key":"529_CR201","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0140-6736(96)10149-5","volume":"349","author":"F Itzhaki Ruth","year":"1997","unstructured":"Itzhaki Ruth F, Lin Woan-Ru S, Dazhuang, Wilcock Gordon K. Faragher brian, Jamieson Gordon A. Herpes simplex virus type 1 in brain and risk of alzheimer\u2019s disease. Lancet. 1997;349:241\u20134.","journal-title":"Lancet"},{"key":"529_CR202","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/alz.12008","volume":"16","author":"M Linard","year":"2020","unstructured":"Linard M, Letenneur L, Garrigue I, Doize A, Dartigues JF, Helmer C. Interaction between APOE4 and herpes simplex virus type 1 in alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2020;16:200\u20138.","journal-title":"Alzheimer\u2019s Dement"},{"key":"529_CR203","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3233\/JAD-171162","volume":"67","author":"H L\u00f6vheim","year":"2019","unstructured":"L\u00f6vheim H, Norman T, Weidung B, Olsson J, Josefsson M, Adolfsson R, et al. Herpes simplex virus, APOE \u03f54, and cognitive decline in old age: results from the Betula cohort study. J Alzheimers Dis. 2019;67:211\u201320.","journal-title":"J Alzheimers Dis"},{"key":"529_CR204","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1042\/bst0260273","volume":"26","author":"RF Itzhaki","year":"1998","unstructured":"Itzhaki RF, Lin WR. Herpes simplex virus type I in brain and the type 4 allele of the Apolipoprotein E gene are a combined risk factor for alzheimer\u2019s disease. Biochem Soc Trans. 1998;26:273\u20137.","journal-title":"Biochem Soc Trans"},{"key":"529_CR205","doi-asserted-by":"publisher","first-page":"5383","DOI":"10.1128\/JVI.00006-06","volume":"80","author":"JS Burgos","year":"2006","unstructured":"Burgos JS, Ramirez C, Sastre I, Valdivieso F. Effect of Apolipoprotein E on the cerebral load of latent herpes simplex virus type 1 DNA. J Virol. 2006;80:5383\u20137.","journal-title":"J Virol"},{"key":"529_CR206","doi-asserted-by":"publisher","first-page":"e01734","DOI":"10.1128\/jvi.00968-24","volume":"98","author":"CS Niemeyer","year":"2024","unstructured":"Niemeyer CS, Merle L, Bubak AN, Baxter BD, Gentile Polese A, Colon-Reyes K, et al. Olfactory and trigeminal routes of HSV-1 CNS infection with regional microglial heterogeneity. J Virol. 2024;98:e01734\u201323.","journal-title":"J Virol"},{"key":"529_CR207","doi-asserted-by":"publisher","first-page":"8146","DOI":"10.1073\/pnas.97.14.8146","volume":"97","author":"EL Bearer","year":"2000","unstructured":"Bearer EL, Breakefield XO, Schuback D, Reese TS, LaVail JH. Retrograde axonal transport of herpes simplex virus: evidence for a single mechanism and a role for tegument. Proc Natl Acad Sci U S A. 2000;97:8146\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"529_CR208","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1128\/JVI.79.3.1605-1612.2005","volume":"79","author":"JS Burgos","year":"2005","unstructured":"Burgos JS, Ramirez C, Sastre I, Alfaro JM, Valdivieso F. Herpes simplex virus type 1 infection via the bloodstream with Apolipoprotein E dependence in the gonads is influenced by gender. J Virol. 2005;79:1605\u20138.","journal-title":"J Virol"},{"key":"529_CR209","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/path.2449","volume":"217","author":"M Wozniak","year":"2009","unstructured":"Wozniak M, Mee AP, Itzhaki RF. Herpes simplex virus type 1 DNA is located within alzheimer\u2019s disease amyloid plaques. J Pathol. 2009;217:131\u20138.","journal-title":"J Pathol"},{"key":"529_CR210","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/sj.bdj.2009.169","volume":"206","author":"R Itzhaki","year":"2009","unstructured":"Itzhaki R, Wozniak M. Herpes simplex virus type 1 in alzheimer\u2019s disease: the enemy within. Br Dent J. 2009;206:267.","journal-title":"Br Dent J"},{"key":"529_CR211","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3233\/JAD-131706","volume":"39","author":"C Martin","year":"2014","unstructured":"Martin C, Aguila B, Araya P, Vio K, Valdivia S, Zambrano A, et al. Inflammatory and neurodegeneration markers during asymptomatic HSV-1 reactivation. J Alzheimers Dis. 2014;39:849\u201359.","journal-title":"J Alzheimers Dis"},{"key":"529_CR212","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3389\/fnagi.2018.00324","volume":"10","author":"RF Itzhaki","year":"2018","unstructured":"Itzhaki RF. Corroboration of a major role for herpes simplex virus type 1 in alzheimer\u2019s disease. Front Aging Neurosci. 2018;10:324.","journal-title":"Front Aging Neurosci"},{"key":"529_CR213","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.neulet.2007.09.077","volume":"429","author":"MA Wozniak","year":"2007","unstructured":"Wozniak MA, Itzhaki RF, Shipley SJ, Dobson CB. Herpes simplex virus infection causes cellular \u03b2-amyloid accumulation and secretase upregulation. Neurosci Lett. 2007;429:95\u2013100.","journal-title":"Neurosci Lett"},{"key":"529_CR214","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1177\/1756285610370069","volume":"3","author":"MA Wozniak","year":"2010","unstructured":"Wozniak MA, Itzhaki RF. Antiviral agents in alzheimer\u2019s disease: hope for the future? Ther Adv Neurol Disord. 2010;3:141\u201352.","journal-title":"Ther Adv Neurol Disord"},{"key":"529_CR215","doi-asserted-by":"publisher","first-page":"9740583","DOI":"10.1155\/2022\/8804925","volume":"2022","author":"T Ge","year":"2022","unstructured":"Ge T, Yuan Y. Herpes simplex virus infection increases beta-amyloid production and induces the development of alzheimer\u2019s disease. Biomed Res Int. 2022;2022:9740583.","journal-title":"Biomed Res Int"},{"key":"529_CR216","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.3233\/JAD-150652","volume":"50","author":"K Bourgade","year":"2016","unstructured":"Bourgade K, Le Page A, Bocti C, Witkowski JM, Dupuis G, Frost EH, et al. Protective effect of amyloid-\u03b2 peptides against herpes simplex virus-1 infection in a neuronal cell culture model. J Alzheimers Dis. 2016;50:1227\u201341.","journal-title":"J Alzheimers Dis"},{"key":"529_CR217","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1093\/gerona\/glu057","volume":"69","author":"C Franceschi","year":"2014","unstructured":"Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol Biol Sci Med Sci. 2014;69:S4\u20139.","journal-title":"J Gerontol Biol Sci Med Sci"},{"key":"529_CR218","doi-asserted-by":"publisher","first-page":"eadf5808","DOI":"10.1126\/sciadv.adf5808","volume":"9","author":"S Fruhw\u00fcrth","year":"2023","unstructured":"Fruhw\u00fcrth S, Reinert LS, \u00d6berg C, Sakr M, Henricsson M, Zetterberg H, et al. TREM2 is down-regulated by HSV1 in microglia and involved in antiviral defense in the brain. Sci Adv. 2023;9:eadf5808.","journal-title":"Sci Adv"},{"key":"529_CR219","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neuron.2018.06.030","volume":"99","author":"WA Eimer","year":"2018","unstructured":"Eimer WA, Vijaya Kumar DK, Navalpur Shanmugam NK, Rodriguez AS, Mitchell T, Washicosky KJ, et al. Alzheimer\u2019s disease-associated \u03b2-amyloid is rapidly seeded by herpesviridae to protect against brain infection. Neuron. 2018;99:56\u2013e633.","journal-title":"Neuron"},{"key":"529_CR220","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3233\/JAD-2009-0963","volume":"16","author":"MA Wozniak","year":"2009","unstructured":"Wozniak MA, Frost AL, Itzhaki RF. Alzheimer\u2019s disease-specific Tau phosphorylation is induced by herpes simplex virus type 1. J Alzheimers Dis. 2009;16:341\u201350.","journal-title":"J Alzheimers Dis"},{"key":"529_CR221","doi-asserted-by":"publisher","first-page":"e01874","DOI":"10.1128\/JVI.01874-19","volume":"94","author":"RD Powell-Doherty","year":"2020","unstructured":"Powell-Doherty RD, Abbott ARN, Nelson LA, Bertke AS. Amyloid- and p-tau anti-threat response to herpes simplex virus 1 infection in primary adult murine hippocampal neurons. J Virol. 2020;94:e01874\u201319.","journal-title":"J Virol"},{"key":"529_CR222","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1007\/s13365-019-00732-3","volume":"25","author":"T Fulop","year":"2019","unstructured":"Fulop T, Witkowski JM, Larbi A, Khalil A, Herbein G, Frost EH. Does HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and alzheimer\u2019s disease? J Neurovirol. 2019;25:634\u201347.","journal-title":"J Neurovirol"},{"key":"529_CR223","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/QAI.0000000000003154","volume":"92","author":"X Yu","year":"2023","unstructured":"Yu X, Kuo YF, Raji MA, Berenson AB, Baillargeon J, Giordano TP. Dementias among older males and females in the U.S. Medicare system with and without HIV. J Acquir Immune Defic Syndr. 2023;92:405\u201312.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"529_CR224","doi-asserted-by":"crossref","first-page":"e0179413","DOI":"10.1371\/journal.pone.0179413","volume":"12","author":"HC Lin","year":"2017","unstructured":"Lin HC, Xirasagar S, Lee HC, Huang CC, Chen CH. Association of alzheimer\u2019s disease with hepatitis C among patients with bipolar disorder. PLoS ONE. 2017;12:e0179413.","journal-title":"PLoS ONE"},{"key":"529_CR225","doi-asserted-by":"crossref","unstructured":"Chiu WC, Tsan YT, Tsai SL, Chang CJ, Wang JD, Chen PC. Hepatitis C viral infection and the risk of dementia. Eur J Neurol. 2014;21(8).","DOI":"10.1111\/ene.12317"},{"key":"529_CR226","doi-asserted-by":"publisher","first-page":"200286","DOI":"10.1098\/rsob.200286","volume":"10","author":"NK Jha","year":"2020","unstructured":"Jha NK, Sharma A, Jha SK, Ojha S, Chellappan DK, Gupta G, et al. Alzheimer\u2019s disease-like perturbations in HIV-mediated neuronal dysfunctions: Understanding mechanisms and developing therapeutic strategies. Open Biol. 2020;10:200286.","journal-title":"Open Biol"},{"key":"529_CR227","doi-asserted-by":"publisher","first-page":"100235","DOI":"10.1016\/j.bbih.2021.100235","volume":"13","author":"S Buckley","year":"2021","unstructured":"Buckley S, Byrnes S, Cochrane C, Roche M, Estes JD, Selemidis S, et al. The role of oxidative stress in HIV-associated neurocognitive disorders. Brain Behav Immun Health. 2021;13:100235.","journal-title":"Brain Behav Immun Health"},{"key":"529_CR228","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1038\/s41467-017-01795-8","volume":"8","author":"Q Chai","year":"2017","unstructured":"Chai Q, Jovasevic V, Malikov V, Sabo Y, Morham S, Walsh D, et al. HIV-1 counteracts an innate restriction by amyloid precursor protein resulting in neurodegeneration. Nat Commun. 2017;8:1522.","journal-title":"Nat Commun"},{"key":"529_CR229","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.mcn.2016.12.006","volume":"79","author":"IE Andr\u00e1s","year":"2017","unstructured":"Andr\u00e1s IE, Leda A, Contreras MG, Bertrand L, Park M, Skowronska M, et al. Extracellular vesicles of the blood-brain barrier: role in the HIV-1 associated amyloid beta pathology. Mol Cell Neurosci. 2017;79:12\u201322.","journal-title":"Mol Cell Neurosci"},{"key":"529_CR230","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2022.07.008","volume":"252","author":"AK Min","year":"2023","unstructured":"Min AK, Fortune T, Rodriguez N, Hedge E, Swartz TH. Inflammasomes as mediators of inflammation in HIV-1 infection. Transl Res. 2023;252:1\u20138.","journal-title":"Transl Res"},{"key":"529_CR231","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00018-025-05685-x","volume":"82","author":"H Zhang","year":"2025","unstructured":"Zhang H, Tan B, Tang T, Tao J, Jin T, Wu S. Targeting inflammasomes as a therapeutic potential for HIV\/AIDS. Cell Mol Life Sci. 2025;82:1\u201312.","journal-title":"Cell Mol Life Sci"},{"key":"529_CR232","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.3748\/wjg.v17.i29.3369","volume":"17","author":"M Senzolo","year":"2011","unstructured":"Senzolo M, Schiff S, D\u2019Aloiso CM, Crivellin C, Cholongitas E, Burra P, et al. Neuropsychological alterations in hepatitis C infection: the role of inflammation. World J Gastroenterol. 2011;17:3369\u201374.","journal-title":"World J Gastroenterol"},{"key":"529_CR233","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s00406-020-01157-4","volume":"271","author":"S Bae","year":"2021","unstructured":"Bae S, Yun SC, Kim MC, Yoon W, Lim JS, Lee SO, et al. Association of herpes Zoster with dementia and effect of antiviral therapy on dementia: a population-based cohort study. Eur Arch Psychiatry Clin Neurosci. 2021;271:987\u201397.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"529_CR234","doi-asserted-by":"publisher","first-page":"e25152","DOI":"10.1371\/journal.pone.0025152","volume":"6","author":"MA Wozniak","year":"2011","unstructured":"Wozniak MA, Frost AL, Preston CM, Itzhaki RF. Antivirals reduce the formation of key alzheimer\u2019s disease molecules in cell cultures acutely infected with herpes simplex virus type 1. PLoS ONE. 2011;6:e25152.","journal-title":"PLoS ONE"},{"key":"529_CR235","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3233\/JAD-2008-13405","volume":"13","author":"RF Itzhaki","year":"2008","unstructured":"Itzhaki RF, Wozniak MA. Herpes simplex virus type 1 in alzheimer\u2019s disease: the enemy within. J Alzheimers Dis. 2008;13:393\u2013405.","journal-title":"J Alzheimers Dis"},{"key":"529_CR236","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0046-8177(87)80252-6","volume":"18","author":"AB MacDonald","year":"1987","unstructured":"MacDonald AB, Miranda JM. Concurrent neocortical borreliosis and alzheimer\u2019s disease. Hum Pathol. 1987;18:759\u201361.","journal-title":"Hum Pathol"},{"key":"529_CR237","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3389\/fnagi.2015.00046","volume":"7","author":"J Miklossy","year":"2015","unstructured":"Miklossy J. Historic evidence to support a causal relationship between spirochetal infections and alzheimer\u2019s disease. Front Aging Neurosci. 2015;7:46.","journal-title":"Front Aging Neurosci"},{"key":"529_CR238","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.neurobiolaging.2005.01.018","volume":"27","author":"J Miklossy","year":"2006","unstructured":"Miklossy J, Kis A, Radenovic A, Miller L, Forro L, Martins R, et al. Beta-amyloid deposition and alzheimer\u2019s type changes induced by Borrelia spirochetes. Neurobiol Aging. 2006;27:228\u201336.","journal-title":"Neurobiol Aging"},{"key":"529_CR239","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3233\/JAD-2004-6608","volume":"6","author":"J Miklossy","year":"2004","unstructured":"Miklossy J, Khalili K, Gern L, Ericson R, Darekar P, Bolle L, et al. Borrelia burgdorferi persists in the brain in chronic Lyme neuroborreliosis and May be associated with alzheimer disease. J Alzheimers Dis. 2004;6:639\u201349.","journal-title":"J Alzheimers Dis"},{"key":"529_CR240","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1742-2094-8-90","volume":"8","author":"J Miklossy","year":"2011","unstructured":"Miklossy J. Alzheimer\u2019s disease - a neurospirochetosis. Analysis of the evidence following koch\u2019s and hill\u2019s criteria. J Neuroinflammation. 2011;8:90.","journal-title":"J Neuroinflammation"},{"key":"529_CR241","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.2741\/hahn","volume":"7","author":"DL Hahn","year":"2002","unstructured":"Hahn DL, Azenabor AA, Beatty WL, Byrne GI. Chlamydia pneumoniae as a respiratory pathogen. Front Biosci. 2002;7:1030\u201349.","journal-title":"Front Biosci"},{"key":"529_CR242","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0197-4580(03)00127-1","volume":"25","author":"CS Little","year":"2004","unstructured":"Little CS, Hammond CJ, MacIntyre A, Balin BJ, Appelt DM. Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of balb\/c mice. Neurobiol Aging. 2004;25:419\u201329.","journal-title":"Neurobiol Aging"},{"key":"529_CR243","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12868-019-0489-5","volume":"20","author":"Z Al-Atrache","year":"2019","unstructured":"Al-Atrache Z, Lopez DB, Hingley ST, Appelt DM. Astrocytes infected with Chlamydia pneumoniae demonstrate altered expression and activity of secretases involved in the generation of \u03b2-amyloid found in alzheimer disease. BMC Neurosci. 2019;20:15.","journal-title":"BMC Neurosci"},{"key":"529_CR244","doi-asserted-by":"publisher","first-page":"723284","DOI":"10.3389\/fnagi.2021.701899","volume":"13","author":"H Ou","year":"2021","unstructured":"Ou H, Chien WC, Chung CH, Chang HA, Kao YC, Wu PC, et al. Association between antibiotic treatment of Chlamydia pneumoniae and reduced risk of alzheimer dementia: A nationwide cohort study in Taiwan. Front Aging Neurosci. 2021;13:723284.","journal-title":"Front Aging Neurosci"},{"key":"529_CR245","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s004300050071","volume":"187","author":"BJ Balin","year":"1998","unstructured":"Balin BJ, G\u00e9rard HC, Arking EJ, Appelt DM, Branigan PJ, Abrams JT, et al. Identification and localization of Chlamydia pneumoniae in the alzheimer\u2019s brain. Med Microbiol Immunol. 1998;187:23\u201342.","journal-title":"Med Microbiol Immunol"},{"key":"529_CR246","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1574-695X.2006.00154.x","volume":"48","author":"HC G\u00e9rard","year":"2006","unstructured":"G\u00e9rard HC, Dreses-Werringloer U, Wildt KS, Deka S, Oszust C, Balin BJ, et al. Chlamydophila (Chlamydia) pneumoniae in the alzheimer\u2019s brain. FEMS Immunol Med Microbiol. 2006;48:355\u201366.","journal-title":"FEMS Immunol Med Microbiol"},{"key":"529_CR247","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/pcn.12637","volume":"72","author":"B Yulug","year":"2018","unstructured":"Yulug B, Hanoglu L, Ozansoy M, Is\u0131k D, Kilic U, Kilic E, et al. Therapeutic role of rifampicin in alzheimer\u2019s disease. Psychiatry Clin Neurosci. 2018;72:152\u20139.","journal-title":"Psychiatry Clin Neurosci"},{"key":"529_CR248","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.brainresbull.2014.05.007","volume":"107","author":"B Yulug","year":"2014","unstructured":"Yulug B, Hanoglu L, Kilic E, Schabitz WR. Rifampicin: an antibiotic with brain protective function. Brain Res Bull. 2014;107:37\u201342.","journal-title":"Brain Res Bull"},{"key":"529_CR249","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1006\/bbrc.1994.2428","volume":"204","author":"T Tomiyama","year":"1994","unstructured":"Tomiyama T, Asano S, Suwa Y, Morita T, Kataoka K, Mori H, et al. Rifampicin prevents the aggregation and neurotoxicity of amyloid beta protein in vitro. Biochem Biophys Res Commun. 1994;204:76\u201383.","journal-title":"Biochem Biophys Res Commun"},{"key":"529_CR250","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1093\/brain\/aww042","volume":"139","author":"T Umeda","year":"2016","unstructured":"Umeda T, Ono K, Sakai A, Yamashita M, Mizuguchi M, Klein WL, et al. Rifampicin is a candidate preventive medicine against amyloid-\u03b2 and Tau oligomers. Brain. 2016;139:1568\u201386.","journal-title":"Brain"},{"key":"529_CR251","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1159\/000477343","volume":"7","author":"T Iizuka","year":"2017","unstructured":"Iizuka T, Morimoto K, Sasaki Y, Kameyama M, Kurashima A, Hayasaka K, et al. Preventive effect of rifampicin on alzheimer disease needs at least 450\u00a0mg daily for 1 year: an FDG-PET follow-up study. Dement Geriatr Cogn Dis Extra. 2017;7:204\u201315.","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"529_CR252","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S0014-5793(00)02380-2","volume":"487","author":"G Forloni","year":"2001","unstructured":"Forloni G, Colombo L, Girola L, Tagliavini F, Salmona M. Anti-amyloidogenic activity of tetracyclines: studies in vitro. FEBS Lett. 2001;487:404\u20137.","journal-title":"FEBS Lett"},{"key":"529_CR253","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.neurobiolaging.2018.06.002","volume":"70","author":"C Balducci","year":"2018","unstructured":"Balducci C, Santamaria G, La Vitola P, Brandi E, Grandi F, Viscomi AR, et al. Doxycycline counteracts neuroinflammation restoring memory in alzheimer\u2019s disease mouse models. Neurobiol Aging. 2018;70:128\u201339.","journal-title":"Neurobiol Aging"},{"key":"529_CR254","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1532-5415.2004.52109.x","volume":"52","author":"MB Loeb","year":"2004","unstructured":"Loeb MB, Molloy DW, Smieja M, Standish T, Goldsmith CH, Mahony J, et al. A randomized, controlled trial of Doxycycline and Rifampin for patients with alzheimer\u2019s disease. J Am Geriatr Soc. 2004;52:381\u20137.","journal-title":"J Am Geriatr Soc"},{"key":"529_CR255","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/gps.3846","volume":"28","author":"DW Molloy","year":"2013","unstructured":"Molloy DW, Standish TI, Zhou Q, Guyatt G. A multicenter, blinded, randomized, factorial controlled trial of Doxycycline and Rifampin for treatment of alzheimer\u2019s disease: the DARAD trial. Int J Geriatr Psychiatry. 2013;28:463\u201370.","journal-title":"Int J Geriatr Psychiatry"},{"key":"529_CR256","doi-asserted-by":"publisher","first-page":"954865","DOI":"10.3389\/fphar.2022.888333","volume":"13","author":"M Kim","year":"2022","unstructured":"Kim M, Park SJ, Choi S, Chang J, Kim SM, Jeong S, et al. Association between antibiotics and dementia risk: A retrospective cohort study. Front Pharmacol. 2022;13:954865.","journal-title":"Front Pharmacol"},{"key":"529_CR257","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12974-019-1494-4","volume":"16","author":"F Angelucci","year":"2019","unstructured":"Angelucci F, Cechova K, Amlerova J, Hort J. Antibiotics, gut microbiota, and alzheimer\u2019s disease. J Neuroinflammation. 2019;16:132.","journal-title":"J Neuroinflammation"},{"key":"529_CR258","doi-asserted-by":"publisher","first-page":"e0264506","DOI":"10.1371\/journal.pone.0264649","volume":"17","author":"RS Mehta","year":"2022","unstructured":"Mehta RS, Lochhead P, Wang Y, Ma W, Nguyen LH, Kochar B, et al. Association of midlife antibiotic use with subsequent cognitive function in women. PLoS ONE. 2022;17:e0264506.","journal-title":"PLoS ONE"},{"key":"529_CR259","doi-asserted-by":"publisher","first-page":"491270","DOI":"10.3389\/fcimb.2020.00104","volume":"10","author":"S Askarova","year":"2020","unstructured":"Askarova S, Umbayev B, Masoud AR, Kaiyrlykyzy A, Safarova Y, Tsoy A, et al. The links between the gut microbiome, aging, modern lifestyle and alzheimer\u2019s disease. Front Cell Infect Microbiol. 2020;10:491270.","journal-title":"Front Cell Infect Microbiol"},{"key":"529_CR260","doi-asserted-by":"publisher","first-page":"1466520","DOI":"10.3389\/fimmu.2024.1466520","volume":"15","author":"J Wang","year":"2024","unstructured":"Wang J, Yan Z, Zhang W, Liu X, Wang J, Peng Q. Upregulation of TREM2 expression in M2 macrophages promotes Brucella abortus chronic infection. Front Immunol. 2024;15:1466520.","journal-title":"Front Immunol"},{"key":"529_CR261","doi-asserted-by":"publisher","first-page":"e01456","DOI":"10.1128\/mbio.01456-22","volume":"13","author":"A Dabla","year":"2022","unstructured":"Dabla A, Liang YC, Rajabalee N, Irwin CJ, Moonen CGJ, Willis JV, et al. TREM2 promotes immune evasion by Mycobacterium tuberculosis in human macrophages. mBio. 2022;13:e01456\u201322.","journal-title":"mBio"},{"key":"529_CR262","doi-asserted-by":"publisher","first-page":"e1011895","DOI":"10.1371\/journal.ppat.1011895","volume":"20","author":"Z Wu","year":"2024","unstructured":"Wu Z, Yang S, Fang X, Shu Q, Chen Q. Function and mechanism of TREM2 in bacterial infection. PLoS Pathog. 2024;20:e1011895.","journal-title":"PLoS Pathog"},{"key":"529_CR263","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1128\/IAI.00115-08","volume":"76","author":"JF Charles","year":"2008","unstructured":"Charles JF, Humphrey MB, Zhao X, Quarles E, Nakamura MC, Aderem A, et al. The innate immune response to Salmonella enterica serovar typhimurium by macrophages is dependent on TREM2-DAP. Infect Immun. 2008;76:2439\u201347.","journal-title":"Infect Immun"},{"key":"529_CR264","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/sji.12148","volume":"79","author":"M Zhu","year":"2014","unstructured":"Zhu M, Li D, Wu Y, Huang X, Wu M. TREM-2 promotes macrophage-mediated eradication of Pseudomonas aeruginosa via a PI3K\/Akt pathway. Scand J Immunol. 2014;79:187\u201396.","journal-title":"Scand J Immunol"},{"key":"529_CR265","doi-asserted-by":"publisher","first-page":"17038","DOI":"10.1038\/nrdp.2017.38","volume":"3","author":"DF Kinane","year":"2017","unstructured":"Kinane DF, Stathopoulou PG, Papapanou PN. Periodontal diseases. Nat Rev Dis Primers. 2017;3:17038.","journal-title":"Nat Rev Dis Primers"},{"key":"529_CR266","doi-asserted-by":"publisher","first-page":"916303","DOI":"10.3389\/fnagi.2022.912709","volume":"14","author":"H Wu","year":"2022","unstructured":"Wu H, Qiu W, Zhu X, Li X, Xie Z, Carreras I, et al. The periodontal pathogen Fusobacterium nucleatum exacerbates alzheimer\u2019s pathogenesis via specific pathways. Front Aging Neurosci. 2022;14:916303.","journal-title":"Front Aging Neurosci"},{"key":"529_CR267","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1177\/0022034514552491","volume":"93","author":"NJ Kassebaum","year":"2014","unstructured":"Kassebaum NJ, Bernab\u00e9 E, Dahiya M, Bhandari B, Murray CJL, Marcenes W. Global burden of severe periodontitis in 1990\u20132010: A systematic review and meta-regression. J Dent Res. 2014;93:1045\u201353.","journal-title":"J Dent Res"},{"key":"529_CR268","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/prd.12429","volume":"89","author":"G Jungbauer","year":"2022","unstructured":"Jungbauer G, St\u00e4hli A, Zhu X, Auber Alberi L, Sculean A, Eick S. Periodontal microorganisms and alzheimer disease\u2013 A causative relationship? Periodontol 2000. 2022;89:59\u201382.","journal-title":"Periodontol 2000"},{"key":"529_CR269","doi-asserted-by":"publisher","first-page":"29143","DOI":"10.3402\/jom.v7.29143","volume":"7","author":"I Olsen","year":"2015","unstructured":"Olsen I, Singhrao SK. Can oral infection be a risk factor for alzheimer\u2019s disease? J Oral Microbiol. 2015;7:29143.","journal-title":"J Oral Microbiol"},{"key":"529_CR270","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/sj.bdj.2014.1137","volume":"218","author":"TL Cerajewska","year":"2015","unstructured":"Cerajewska TL, Davies M, West NX, Periodontitis. A potential risk factor for alzheimer\u2019s disease. Br Dent J. 2015;218:29\u201334.","journal-title":"Br Dent J"},{"key":"529_CR271","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3389\/fnagi.2017.00327","volume":"9","author":"FB Teixeira","year":"2017","unstructured":"Teixeira FB, Saito MT, Matheus FC, Prediger RD, Yamada ES, Maia CSF, et al. Periodontitis and alzheimer\u2019s disease: A possible comorbidity between oral chronic inflammatory condition and neuroinflammation. Front Aging Neurosci. 2017;9:327.","journal-title":"Front Aging Neurosci"},{"key":"529_CR272","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.3233\/JAD-160212","volume":"52","author":"JAF Cestari","year":"2016","unstructured":"Cestari JAF, Fabri GMC, Kalil J, Nitrini R, Jacob-Filho W, De Siqueira JTT, et al. Oral infections and cytokine levels in patients with alzheimer\u2019s disease and mild cognitive impairment compared with controls. J Alzheimers Dis. 2016;52:1479\u201385.","journal-title":"J Alzheimers Dis"},{"key":"529_CR273","doi-asserted-by":"publisher","first-page":"e0151081","DOI":"10.1371\/journal.pone.0151081","volume":"11","author":"M Ide","year":"2016","unstructured":"Ide M, Harris M, Stevens A, Sussams R, Hopkins V, Culliford D, et al. Periodontitis and cognitive decline in alzheimer\u2019s disease. PLoS ONE. 2016;11:e0151081.","journal-title":"PLoS ONE"},{"key":"529_CR274","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13195-017-0282-6","volume":"9","author":"CK Chen","year":"2017","unstructured":"Chen CK, Wu YT, Chang YC. Association between chronic periodontitis and the risk of alzheimer\u2019s disease: A retrospective, population-based, matched-cohort study. Alzheimers Res Ther. 2017;9:56.","journal-title":"Alzheimers Res Ther"},{"key":"529_CR275","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1111\/jgs.15828","volume":"67","author":"S Choi","year":"2019","unstructured":"Choi S, Kim K, Chang J, Kim SM, Kim SJ, Cho HJ, et al. Association of chronic periodontitis on alzheimer\u2019s disease or vascular dementia. J Am Geriatr Soc. 2019;67:1234\u20139.","journal-title":"J Am Geriatr Soc"},{"key":"529_CR276","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3233\/JAD-200385","volume":"87","author":"V Panzarella","year":"2022","unstructured":"Panzarella V, Mauceri R, Baschi R, Maniscalco L, Campisi G, Monastero R. Oral health status in subjects with amnestic mild cognitive impairment and alzheimer\u2019s disease: data from the Zab\u00fat aging project. J Alzheimers Dis. 2022;87:173\u201382.","journal-title":"J Alzheimers Dis"},{"key":"529_CR277","doi-asserted-by":"publisher","first-page":"e114959","DOI":"10.1371\/journal.pone.0114959","volume":"9","author":"JM Noble","year":"2014","unstructured":"Noble JM, Scarmeas N, Celenti RS, Elkind MSV, Wright CB, Schupf N, et al. Serum IgG antibody levels to periodontal microbiota are associated with incident alzheimer disease. PLoS ONE. 2014;9:e114959.","journal-title":"PLoS ONE"},{"key":"529_CR278","doi-asserted-by":"publisher","first-page":"eaau3333","DOI":"10.1126\/sciadv.aau3333","volume":"5","author":"SS Dominy","year":"2019","unstructured":"Dominy SS, Lynch C, Ermini F, Benedyk M, Marczyk A, Konradi A, et al. Porphyromonas gingivalis in alzheimer\u2019s disease brains: evidence for disease causation and treatment with small-molecule inhibitors. Sci Adv. 2019;5:eaau3333.","journal-title":"Sci Adv"},{"key":"529_CR279","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12979-017-0110-7","volume":"15","author":"Y Ding","year":"2018","unstructured":"Ding Y, Ren J, Yu H, Yu W, Zhou Y. Porphyromonas gingivalis, a periodontitis-causing bacterium, induces memory impairment and age-dependent neuroinflammation in mice. Immun Ageing. 2018;15:6.","journal-title":"Immun Ageing"},{"key":"529_CR280","doi-asserted-by":"publisher","first-page":"588036","DOI":"10.3389\/fimmu.2020.588036","volume":"11","author":"J D\u00edaz-Z\u00fa\u00f1iga","year":"2020","unstructured":"D\u00edaz-Z\u00fa\u00f1iga J, More J, Melgar-Rodr\u00edguez S, Jim\u00e9nez-Uni\u00f3n M, Villalobos-Orchard F, Mu\u00f1oz-Manr\u00edquez C, et al. Alzheimer\u2019s disease-like pathology triggered by Porphyromonas gingivalis in wild type rats is serotype dependent. Front Immunol. 2020;11:588036.","journal-title":"Front Immunol"},{"key":"529_CR281","doi-asserted-by":"publisher","first-page":"710","DOI":"10.3389\/fnins.2020.00658","volume":"14","author":"Y Hu","year":"2020","unstructured":"Hu Y, Li H, Zhang J, Zhang X, Xia X, Qiu C, et al. Periodontitis induced by P. gingivalis-LPS is associated with neuroinflammation and learning and memory impairment in Sprague-Dawley rats. Front Neurosci. 2020;14:710.","journal-title":"Front Neurosci"},{"key":"529_CR282","doi-asserted-by":"publisher","first-page":"1141339","DOI":"10.3389\/fncel.2023.1141339","volume":"17","author":"R Jin","year":"2023","unstructured":"Jin R, Ning X, Liu X, Zhao Y, Ye G. Porphyromonas gingivalis-induced periodontitis could contribute to cognitive impairment in Sprague\u2013Dawley rats via the P38 MAPK signaling pathway. Front Cell Neurosci. 2023;17:1141339.","journal-title":"Front Cell Neurosci"},{"key":"529_CR283","doi-asserted-by":"publisher","first-page":"e35340","DOI":"10.1016\/j.heliyon.2024.e35340","volume":"10","author":"X Li","year":"2024","unstructured":"Li X, Yao C, Lan D, Chen Y, Wang Y, Qi S. Porphyromonas gingivalis promote microglia M1 polarization through the NF-\u043aB signaling pathway. Heliyon. 2024;10:e35340.","journal-title":"Heliyon"},{"key":"529_CR284","doi-asserted-by":"publisher","first-page":"e0204941","DOI":"10.1371\/journal.pone.0204941","volume":"13","author":"V Ilievski","year":"2018","unstructured":"Ilievski V, Zuchowska PK, Green SJ, Toth PT, Ragozzino ME, Le K, et al. Chronic oral application of a periodontal pathogen results in brain inflammation, neurodegeneration and amyloid beta production in wild type mice. PLoS ONE. 2018;13:e0204941.","journal-title":"PLoS ONE"},{"key":"529_CR285","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.bbi.2017.06.002","volume":"65","author":"Z Wu","year":"2017","unstructured":"Wu Z, Ni J, Liu Y, Teeling JL, Takayama F, Collcutt A, et al. Cathepsin B plays a critical role in inducing alzheimer\u2019s disease-like phenotypes following chronic systemic exposure to lipopolysaccharide from Porphyromonas gingivalis in mice. Brain Behav Immun. 2017;65:350\u201361.","journal-title":"Brain Behav Immun"},{"key":"529_CR286","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.4049\/jimmunol.0800909","volume":"182","author":"M Tze","year":"2009","unstructured":"Tze M, Huang H, Taxman DJ, Holley-Guthrie EA, Moore CB, Willingham SB, et al. Critical role of apoptotic speck protein containing a caspase recruitment domain (ASC) and NLRP3 in causing necrosis and ASC speck formation induced by Porphyromonas gingivalis in human cells. J Immunol. 2009;182:2395\u2013404.","journal-title":"J Immunol"},{"key":"529_CR287","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00011-016-0992-4","volume":"66","author":"Y Yamaguchi","year":"2017","unstructured":"Yamaguchi Y, Kurita-Ochiai T, Kobayashi R, Suzuki T, Ando T. Regulation of the NLRP3 inflammasome in Porphyromonas gingivalis-accelerated periodontal disease. Inflamm Res. 2017;66:59\u201365.","journal-title":"Inflamm Res"},{"key":"529_CR288","doi-asserted-by":"publisher","first-page":"101849","DOI":"10.1016\/j.redox.2020.101849","volume":"40","author":"Y Weng","year":"2020","unstructured":"Weng Y, Wang H, Li L, Feng Y, Xu S, Wang Z. TREM2-mediated Syk-dependent ROS amplification is essential for osteoclastogenesis in periodontitis microenvironment. Redox Biol. 2020;40:101849.","journal-title":"Redox Biol"},{"key":"529_CR289","doi-asserted-by":"publisher","first-page":"17999","DOI":"10.1038\/s41598-020-75517-4","volume":"10","author":"A Kantarci","year":"2020","unstructured":"Kantarci A, Tognoni CM, Yaghmoor W, Marghalani A, Stephens D, Ahn JY, et al. Microglial response to experimental periodontitis in a murine model of alzheimer\u2019s disease. Sci Rep. 2020;10:17999.","journal-title":"Sci Rep"},{"key":"529_CR290","doi-asserted-by":"publisher","first-page":"1322444","DOI":"10.1080\/20002297.2016.1270602","volume":"9","author":"SK Singhrao","year":"2017","unstructured":"Singhrao SK, Chukkapalli S, Poole S, Velsko I, Crean SJ, Kesavalu L. Chronic Porphyromonas gingivalis infection accelerates the occurrence of age-related granules in ApoE\u2013\/\u2013 mice brains. J Oral Microbiol. 2017;9:1322444.","journal-title":"J Oral Microbiol"},{"key":"529_CR291","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3233\/JAD-121918","volume":"36","author":"S Poole","year":"2013","unstructured":"Poole S, Singhrao SK, Kesavalu L, Curtis MA, Crean SJ. Determining the presence of periodontopathic virulence factors in short-term postmortem alzheimer\u2019s disease brain tissue. J Alzheimers Dis. 2013;36:665\u201377.","journal-title":"J Alzheimers Dis"},{"key":"529_CR292","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1177\/0022034520933533","volume":"99","author":"Y Zang","year":"2020","unstructured":"Zang Y, Song JH, Oh SH, Kim JW, Lee MN, Piao X, et al. Targeting NLRP3 inflammasome reduces age-related experimental alveolar bone loss. J Dent Res. 2020;99:1287\u201395.","journal-title":"J Dent Res"},{"key":"529_CR293","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/jre.12731","volume":"55","author":"Y Arita","year":"2020","unstructured":"Arita Y, Yoshinaga Y, Kaneko T, Kawahara Y, Nakamura K, Ohgi K, et al. Glyburide inhibits the bone resorption induced by traumatic occlusion in rats. J Periodontal Res. 2020;55:464\u201371.","journal-title":"J Periodontal Res"},{"key":"529_CR294","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/jre.12974","volume":"57","author":"M Jiang","year":"2022","unstructured":"Jiang M, Shang Z, Zhang T, Yin X, Liang X, Sun H. Study on the role of pyroptosis in bone resorption induced by occlusal trauma with or without periodontitis. J Periodontal Res. 2022;57:448\u201360.","journal-title":"J Periodontal Res"},{"key":"529_CR295","first-page":"49","volume":"2","author":"AR Kamer","year":"2016","unstructured":"Kamer AR, Fortea JO, Videla S, Mayoral A, Janal M, Carmona-Iragui M, et al. Periodontal disease\u2019s contribution to alzheimer\u2019s disease progression in down syndrome. Alzheimers Dement Diagn Assess Dis Monit. 2016;2:49.","journal-title":"Alzheimers Dement Diagn Assess Dis Monit"},{"key":"529_CR296","doi-asserted-by":"publisher","first-page":"110112","DOI":"10.1016\/j.pnpbp.2020.110112","volume":"106","author":"D Goyal","year":"2021","unstructured":"Goyal D, Ali SA, Singh RK. Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on alzheimer\u2019s disease. Prog Neuropsychopharmacol Biol Psychiatry. 2021;106:110112.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"529_CR297","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41569-022-00737-2","volume":"20","author":"F Violi","year":"2022","unstructured":"Violi F, Cammisotto V, Bartimoccia S, Pignatelli P, Carnevale R, Nocella C. Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease. Nat Rev Cardiol. 2022;20:24\u201337.","journal-title":"Nat Rev Cardiol"},{"key":"529_CR298","doi-asserted-by":"publisher","first-page":"480172","DOI":"10.3389\/fcimb.2019.00409","volume":"9","author":"J Wang","year":"2019","unstructured":"Wang J, Gu X, Yang J, Wei Y, Zhao Y. Gut microbiota dysbiosis and increased plasma LPS and TMAO levels in patients with preeclampsia. Front Cell Infect Microbiol. 2019;9:480172.","journal-title":"Front Cell Infect Microbiol"},{"key":"529_CR299","doi-asserted-by":"publisher","first-page":"30028","DOI":"10.1038\/srep30028","volume":"6","author":"MR Minter","year":"2016","unstructured":"Minter MR, Zhang C, Leone V, Ringus DL, Zhang X, Oyler-Castrillo P, et al. Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of alzheimer\u2019s disease. Sci Rep. 2016;6:30028.","journal-title":"Sci Rep"},{"key":"529_CR300","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/j.csbj.2023.03.017","volume":"21","author":"D Yang","year":"2023","unstructured":"Yang D, Wang Z, Chen Y, Guo Q, Dong Y. Interactions between gut microbes and NLRP3 inflammasome in the gut-brain axis. Comput Struct Biotechnol J. 2023;21:2215.","journal-title":"Comput Struct Biotechnol J"},{"key":"529_CR301","doi-asserted-by":"publisher","first-page":"109884","DOI":"10.1016\/j.pnpbp.2020.109884","volume":"100","author":"H Shen","year":"2020","unstructured":"Shen H, Guan Q, Zhang X, Yuan C, Tan Z, Zhai L, et al. New mechanism of neuroinflammation in alzheimer\u2019s disease: the activation of NLRP3 inflammasome mediated by gut microbiota. Prog Neuropsychopharmacol Biol Psychiatry. 2020;100:109884.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"529_CR302","doi-asserted-by":"publisher","first-page":"10667","DOI":"10.1371\/journal.pone.0010667","volume":"5","author":"E Biagi","year":"2010","unstructured":"Biagi E, Nylund L, Candela M, Ostan R, Bucci L, Pini E, et al. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS ONE. 2010;5:10667.","journal-title":"PLoS ONE"},{"key":"529_CR303","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.jalz.2019.07.002","volume":"15","author":"B Li","year":"2019","unstructured":"Li B, He Y, Ma J, Huang P, Du J, Cao L, et al. Mild cognitive impairment has similar alterations as alzheimer\u2019s disease in gut microbiota. Alzheimers Dement. 2019;15:1357\u201366.","journal-title":"Alzheimers Dement"},{"key":"529_CR304","doi-asserted-by":"publisher","first-page":"52246","DOI":"10.1038\/s41598-024-52246-6","volume":"14","author":"P Saha","year":"2024","unstructured":"Saha P, Weigle IQ, Slimmon N, Poli PB, Patel P, Zhang X, et al. Early modulation of the gut Microbiome by female sex hormones alters amyloid pathology and microglial function. Sci Rep. 2024;14:52246.","journal-title":"Sci Rep"},{"key":"529_CR305","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13024-024-00708-w","volume":"19","author":"ME Bosch","year":"2024","unstructured":"Bosch ME, Dodiya HB, Michalkiewicz J, Lee C, Shaik SM, Weigle IQ, et al. Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner. Mol Neurodegener. 2024;19:26.","journal-title":"Mol Neurodegener"},{"key":"529_CR306","doi-asserted-by":"publisher","first-page":"S95","DOI":"10.1093\/infdis\/jiae165","volume":"230","author":"G Park","year":"2024","unstructured":"Park G, Kadyan S, Hochuli N, Salazar G, Laitano O, Chakrabarty P, et al. An enteric bacterial infection triggers neuroinflammation and neurobehavioral impairment in 3xTg-AD Transgenic mice. J Infect Dis. 2024;230:S95\u2013108.","journal-title":"J Infect Dis"},{"key":"529_CR307","first-page":"144589","volume":"11","author":"CH Chen","year":"2016","unstructured":"Chen CH, Lin CL, Kao CH. Irritable bowel syndrome is associated with an increased risk of dementia: A nationwide population-based study. PLoS ONE. 2016;11:144589.","journal-title":"PLoS ONE"},{"key":"529_CR308","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.dld.2016.07.008","volume":"48","author":"S Caini","year":"2016","unstructured":"Caini S, Bagnoli S, Palli D, Saieva C, Ceroti M, Bendinelli B, et al. Total and cancer mortality in a cohort of ulcerative colitis and crohn\u2019s disease patients: the Florence inflammatory bowel disease study, 1978\u20132010. Dig Liver Dis. 2016;48:1162\u20137.","journal-title":"Dig Liver Dis"},{"key":"529_CR309","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1001\/jama.1996.03540120033030","volume":"276","author":"L White","year":"1996","unstructured":"White L, Petrovitch H, Ross GW, Masaki KH, Abbott RD, Teng EL, et al. Prevalence of dementia in older Japanese-American men in hawaii: the Honolulu-Asia aging study. JAMA. 1996;276:955\u201360.","journal-title":"JAMA"},{"key":"529_CR310","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/nu14010020","volume":"14","author":"R Naomi","year":"2022","unstructured":"Naomi R, Embong H, Othman F, Ghazi HF, Maruthey N, Bahari H. Probiotics for alzheimer\u2019s disease: A systematic review. Nutrients. 2022;14:20.","journal-title":"Nutrients"},{"key":"529_CR311","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1136\/gutjnl-2018-317431","volume":"69","author":"MS Kim","year":"2020","unstructured":"Kim MS, Kim Y, Choi H, Kim W, Park S, Lee D, et al. Transfer of a healthy microbiota reduces amyloid and Tau pathology in an alzheimer\u2019s disease animal model. Gut. 2020;69:283\u201394.","journal-title":"Gut"},{"key":"529_CR312","doi-asserted-by":"publisher","first-page":"843105","DOI":"10.3389\/fnins.2022.843105","volume":"16","author":"TS Webberley","year":"2022","unstructured":"Webberley TS, Masetti G, Bevan RJ, Kerry-Smith J, Jack AA, Michael DR, et al. The impact of probiotic supplementation on cognitive, pathological and metabolic markers in a Transgenic mouse model of alzheimer\u2019s disease. Front Neurosci. 2022;16:843105.","journal-title":"Front Neurosci"},{"key":"529_CR313","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3389\/fnagi.2016.00256","volume":"8","author":"E Akbari","year":"2016","unstructured":"Akbari E, Asemi Z, Kakhaki RD, Bahmani F, Kouchaki E, Tamtaji OR, et al. Effect of probiotic supplementation on cognitive function and metabolic status in alzheimer\u2019s disease: A randomized, double-blind and controlled trial. Front Aging Neurosci. 2016;8:256.","journal-title":"Front Aging Neurosci"},{"key":"529_CR314","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1212\/WNL.0b013e3182190d09","volume":"76","author":"WL Xu","year":"2011","unstructured":"Xu WL, Atti AR, Gatz M, Pedersen NL, Johansson B, Fratiglioni L. Midlife overweight and obesity increase late-life dementia risk: A population-based twin study. Neurology. 2011;76:1568.","journal-title":"Neurology"},{"key":"529_CR315","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/ijo.2009.104","volume":"33","author":"LB Hassing","year":"2009","unstructured":"Hassing LB, Dahl AK, Thorvaldsson V, Berg S, Gatz M, Pedersen NL, et al. Overweight in midlife and risk of dementia: A 40-year follow-up study. Int J Obes (Lond). 2009;33:893.","journal-title":"Int J Obes (Lond)"},{"key":"529_CR316","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1001\/archinte.163.13.1524","volume":"163","author":"D Gustafson","year":"2003","unstructured":"Gustafson D, Rothenberg E, Blennow K, Steen B, Skoog I. An 18-year follow-up of overweight and risk of alzheimer disease. Arch Intern Med. 2003;163:1524\u20138.","journal-title":"Arch Intern Med"},{"key":"529_CR317","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1136\/bmj.38446.466238.E0","volume":"330","author":"RA Whitmer","year":"2005","unstructured":"Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry CP, Yaffe K. Obesity in middle age and future risk of dementia: A 27 year longitudinal population based study. BMJ. 2005;330:1360.","journal-title":"BMJ"},{"key":"529_CR318","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.18632\/aging.102738","volume":"12","author":"Z Sun","year":"2020","unstructured":"Sun Z, Wang ZT, Sun FR, Shen XN, Xu W, Ma YH, et al. Late-life obesity is a protective factor for prodromal alzheimer\u2019s disease: A longitudinal study. Aging. 2020;12:2005.","journal-title":"Aging"},{"key":"529_CR319","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.1532-5415.2007.01458.x","volume":"56","author":"AR Atti","year":"2008","unstructured":"Atti AR, Palmer K, Volpato S, Winblad B, De Ronchi D, Fratiglioni L. Late-life body mass index and dementia incidence: Nine-year follow-up data from the kungsholmen project. J Am Geriatr Soc. 2008;56:111\u20136.","journal-title":"J Am Geriatr Soc"},{"key":"529_CR320","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1212\/01.WNL.0000038910.46217.AA","volume":"60","author":"F Nourhash\u00e9mi","year":"2003","unstructured":"Nourhash\u00e9mi F, Deschamps V, Larrieu S, Letenneur L, Dartigues JF, Barberger-Gateau P. Body mass index and incidence of dementia: the PAQUID study. Neurology. 2003;60:117\u20139.","journal-title":"Neurology"},{"key":"529_CR321","doi-asserted-by":"publisher","first-page":"34691","DOI":"10.18632\/oncotarget.26162","volume":"9","author":"J Pegueroles","year":"2018","unstructured":"Pegueroles J, Jim\u00e9nez A, Vilaplana E, Montal V, Carmona-Iragui M, Pan\u00e9 A, et al. Obesity and alzheimer\u2019s disease, does the obesity paradox really exist? A magnetic resonance imaging study. Oncotarget. 2018;9:34691.","journal-title":"Oncotarget"},{"key":"529_CR322","doi-asserted-by":"publisher","first-page":"104706","DOI":"10.18632\/oncotarget.22218","volume":"8","author":"A Jimenez","year":"2017","unstructured":"Jimenez A, Pegueroles J, Carmona-Iragui M, Vilaplana E, Montal V, Alcolea D, et al. Weight loss in the healthy elderly might be a non-cognitive sign of preclinical alzheimer\u2019s disease. Oncotarget. 2017;8:104706\u201316.","journal-title":"Oncotarget"},{"key":"529_CR323","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1212\/01.wnl.0000271381.30143.75","volume":"69","author":"E n Den Berg","year":"2007","unstructured":"n Den Berg E, Biessels GJ, De Craen AJM, Gussekloo J, Westendorp RGJ. The metabolic syndrome is associated with decelerated cognitive decline in the oldest old. Neurology. 2007;69:979\u201385.","journal-title":"Neurology"},{"key":"529_CR324","doi-asserted-by":"publisher","first-page":"849","DOI":"10.2147\/DMSO.S393282","volume":"16","author":"HN Alsuwaidi","year":"2023","unstructured":"Alsuwaidi HN, Ahmed AI, Alkorbi HA, Ali SM, Altarawneh LN, Uddin SI, et al. Association between metabolic syndrome and decline in cognitive function: A cross-sectional study. Diabetes Metab Syndr Obes. 2023;16:849.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"529_CR325","doi-asserted-by":"publisher","first-page":"4354","DOI":"10.3390\/ijms24054354","volume":"24","author":"A Ezkurdia","year":"2023","unstructured":"Ezkurdia A, Ram\u00edrez MJ, Solas M. Metabolic syndrome as a risk factor for alzheimer\u2019s disease: A focus on insulin resistance. Int J Mol Sci. 2023;24:4354.","journal-title":"Int J Mol Sci"},{"key":"529_CR326","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1001\/archneur.64.1.93","volume":"64","author":"G Razay","year":"2007","unstructured":"Razay G, Vreugdenhil A, Wilcock G. The metabolic syndrome and alzheimer disease. Arch Neurol. 2007;64:93\u20136.","journal-title":"Arch Neurol"},{"key":"529_CR327","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/alz.13439","volume":"20","author":"D Qureshi","year":"2024","unstructured":"Qureshi D, Collister J, Allen NE, Ku\u017ama E, Littlejohns T. Association between metabolic syndrome and risk of incident dementia in UK biobank. Alzheimer\u2019s Dement. 2024;20:447\u201358.","journal-title":"Alzheimer\u2019s Dement"},{"key":"529_CR328","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.14283\/jpad.2024.90","volume":"11","author":"I Frentz","year":"2024","unstructured":"Frentz I, Marcolini S, Schneider CCI, Ikram MA, Mondragon J, De Deyn PP. Metabolic syndrome status changes and cognitive functioning: insights from the lifelines cohort study. J Prev Alzheimers Dis. 2024;11:1283.","journal-title":"J Prev Alzheimers Dis"},{"key":"529_CR329","doi-asserted-by":"crossref","unstructured":"Khanna D, Khanna S, Khanna P, Kahar P, Patel BM. Obesity: A chronic Low-Grade inflammation and its markers. Cureus. 2022;14.","DOI":"10.7759\/cureus.22711"},{"key":"529_CR330","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.diabres.2004.11.007","volume":"69","author":"HS Park","year":"2005","unstructured":"Park HS, Park JY, Yu R. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-\u03b1 and IL-6. Diabetes Res Clin Pract. 2005;69:29\u201335.","journal-title":"Diabetes Res Clin Pract"},{"key":"529_CR331","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1080\/13813450802181047","volume":"114","author":"I Nieto-Vazquez","year":"2008","unstructured":"Nieto-Vazquez I, Fern\u00e1ndez-Veledo S, Kr\u00e4mer DK, Vila-Bedmar R, Garcia-Guerra L, Lorenzo M. Insulin resistance associated to obesity: the link TNF-alpha. Arch Physiol Biochem. 2008;114:183\u201394.","journal-title":"Arch Physiol Biochem"},{"key":"529_CR332","first-page":"272","volume":"84","author":"B Zinman","year":"1999","unstructured":"Zinman B, Hanley AJG, Harris SB, Kwan J, Fantus IG. Circulating tumor necrosis Factor-\u03b1 concentrations in a native Canadian population with high rates of type 2 diabetes mellitus. J Clin Endocrinol Metab. 1999;84:272\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"529_CR333","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1111\/j.1471-4159.2012.07660.x","volume":"120","author":"S Gupta","year":"2012","unstructured":"Gupta S, Knight AG, Gupta S, Keller JN, Bruce-Keller AJ. Saturated long chain fatty acids activate inflammatory signaling in astrocytes. J Neurochem. 2012;120:1060.","journal-title":"J Neurochem"},{"key":"529_CR334","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.bbadis.2016.04.017","volume":"1863","author":"S Pugazhenthi","year":"2017","unstructured":"Pugazhenthi S, Qin L, Reddy PH. Common neurodegenerative pathways in obesity, diabetes, and alzheimer\u2019s disease. Biochim Biophys Acta. 2017;1863:1037.","journal-title":"Biochim Biophys Acta"},{"key":"529_CR335","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nm.2279","volume":"17","author":"B Vandanmagsar","year":"2011","unstructured":"Vandanmagsar B, Youm YH, Ravussin A, Galgani JE, Stadler K, Mynatt RL, et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med. 2011;17:179\u201388.","journal-title":"Nat Med"},{"key":"529_CR336","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1124\/jpet.123.002013","volume":"388","author":"P Thornton","year":"2024","unstructured":"Thornton P, Reader V, Digby Z, Smolak P, Lindsay N, Harrison D, et al. Reversal of high fat Diet-Induced obesity, systemic inflammation, and astrogliosis by the NLRP3 inflammasome inhibitors NT-0249 and NT-0796. J Pharmacol Exp Ther. 2024;388:813\u201326.","journal-title":"J Pharmacol Exp Ther"},{"key":"529_CR337","doi-asserted-by":"crossref","unstructured":"Telemaco Contreras Colmenares M, de Oliveira Matos A, Henrique dos Santos Dantas P, Rodrigues do Carmo Neto, Silva-Sales J, Sales-Campos M. H. Unveiling the impact of TREM-2\u2009+\u2009Macrophages in metabolic disorders. Cell Immunol. 2024;405:104882.","DOI":"10.1016\/j.cellimm.2024.104882"},{"key":"529_CR338","doi-asserted-by":"publisher","first-page":"e70338","DOI":"10.1111\/cns.70338","volume":"31","author":"C Zhao","year":"2025","unstructured":"Zhao C, Qi W, Lv X, Gao X, Liu C, Zheng S. Elucidating the role of Trem2 in lipid metabolism and neuroinflammation. CNS Neurosci Ther. 2025;31:e70338.","journal-title":"CNS Neurosci Ther"},{"key":"529_CR339","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1001\/archneurol.2007.29","volume":"65","author":"F Irie","year":"2008","unstructured":"Irie F, Fitzpatrick AL, Lopez OL, Kuller LH, Peila R, Newman AB, et al. Enhanced risk for alzheimer disease in persons with type 2 diabetes and APOE \u03b54: the cardiovascular health study cognition study. Arch Neurol. 2008;65:89\u201393.","journal-title":"Arch Neurol"},{"key":"529_CR340","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1001\/archneur.61.5.661","volume":"61","author":"Z Arvanitakis","year":"2004","unstructured":"Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Bennett DA. Diabetes mellitus and risk of alzheimer disease and decline in cognitive function. Arch Neurol. 2004;61:661\u20136.","journal-title":"Arch Neurol"},{"key":"529_CR341","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/j.1749-6632.1997.tb48496.x","volume":"826","author":"CL Leibson","year":"1997","unstructured":"Leibson CL, Rocca WA, Hanson VA, Cha R, Kokmen E, O\u2019Brien PC, et al. The risk of dementia among persons with diabetes mellitus: A Population-Based cohort studya. Ann N Y Acad Sci. 1997;826:422\u20137.","journal-title":"Ann N Y Acad Sci"},{"key":"529_CR342","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1212\/WNL.53.9.1937","volume":"53","author":"A Ott","year":"1999","unstructured":"Ott A, Stolk RP, Van Harskamp F, Pols HAP, Hofman A, Breteler MMB. Diabetes mellitus and the risk of dementia: the Rotterdam study. Neurology. 1999;53:1937\u201342.","journal-title":"Neurology"},{"key":"529_CR343","doi-asserted-by":"publisher","first-page":"309307","DOI":"10.3389\/fnagi.2017.00345","volume":"9","author":"BJ Neth","year":"2017","unstructured":"Neth BJ, Craft S. Insulin resistance and alzheimer\u2019s disease: bioenergetic linkages. Front Aging Neurosci. 2017;9:309307.","journal-title":"Front Aging Neurosci"},{"key":"529_CR344","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/S0165-6147(02)02037-0","volume":"23","author":"L Gasparini","year":"2002","unstructured":"Gasparini L, Netzer WJ, Greengard P, Xu H. Does insulin dysfunction play a role in alzheimer\u2019s disease? Trends Pharmacol Sci. 2002;23:288\u201393.","journal-title":"Trends Pharmacol Sci"},{"key":"529_CR345","doi-asserted-by":"publisher","first-page":"e32792","DOI":"10.1371\/journal.pone.0032792","volume":"7","author":"L Devi","year":"2012","unstructured":"Devi L, Alldred MJ, Ginsberg SD, Ohno M. Mechanisms underlying insulin Deficiency-Induced acceleration of \u03b2-Amyloidosis in a mouse model of alzheimer\u2019s disease. PLoS ONE. 2012;7:e32792.","journal-title":"PLoS ONE"},{"key":"529_CR346","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0014-5793(94)00387-4","volume":"345","author":"IV Kurochkin","year":"1994","unstructured":"Kurochkin IV, Goto S. Alzheimer\u2019s \u03b2-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Lett. 1994;345:33\u20137.","journal-title":"FEBS Lett"},{"key":"529_CR347","doi-asserted-by":"publisher","first-page":"32730","DOI":"10.1074\/jbc.273.49.32730","volume":"273","author":"WQ Qiu","year":"1998","unstructured":"Qiu WQ, Walsh DM, Ye Z, Vekrellis K, Zhang J, Podlisny MB, et al. Insulin-degrading enzyme regulates extracellular levels of amyloid \u03b2-protein by degradation. J Biol Chem. 1998;273:32730\u20138.","journal-title":"J Biol Chem"},{"key":"529_CR348","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-023-02914-7","volume":"20","author":"M Corraliza-Gomez","year":"2023","unstructured":"Corraliza-Gomez M, Bermejo T, Lilue J, Rodriguez-Iglesias N, Valero J, Cozar-Castellano I, et al. Insulin-degrading enzyme (IDE) as a modulator of microglial phenotypes in the context of alzheimer\u2019s disease and brain aging. J Neuroinflamm. 2023;20:1\u201321.","journal-title":"J Neuroinflamm"},{"key":"529_CR349","doi-asserted-by":"publisher","first-page":"575","DOI":"10.18632\/aging.100921","volume":"8","author":"J Miklossy","year":"2016","unstructured":"Miklossy J, McGeer PL. Common mechanisms involved in alzheimer\u2019s disease and type 2 diabetes: a key role of chronic bacterial infection and inflammation. Aging. 2016;8:575.","journal-title":"Aging"},{"key":"529_CR350","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1126\/science.7678183","volume":"259","author":"GS Hotamisligil","year":"1993","unstructured":"Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis Factor-\u03b1: direct role in Obesity-Linked insulin. Science. 1993;259:87\u201391.","journal-title":"Science"},{"key":"529_CR351","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.1038\/sj.ijo.0802502","volume":"27","author":"GS Hotamisligil","year":"2003","unstructured":"Hotamisligil GS. Inflammatory pathways and insulin action. Int J Obes. 2003;27:S53\u20135.","journal-title":"Int J Obes"},{"key":"529_CR352","doi-asserted-by":"publisher","first-page":"194","DOI":"10.2337\/db12-0420","volume":"62","author":"HM Lee","year":"2013","unstructured":"Lee HM, Kim JJ, Kim HJ, Shong M, Ku BJ, Jo EK. Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes. Diabetes. 2013;62:194\u2013204.","journal-title":"Diabetes"},{"key":"529_CR353","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.2337\/db13-1954","volume":"63","author":"FG De Felice","year":"2014","unstructured":"De Felice FG, Ferreira ST. Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to alzheimer disease. Diabetes. 2014;63:2262\u201372.","journal-title":"Diabetes"},{"key":"529_CR354","doi-asserted-by":"publisher","first-page":"E963","DOI":"10.1210\/clinem\/dgz234","volume":"105","author":"JK Sluggett","year":"2020","unstructured":"Sluggett JK, Koponen M, Simon Bell J, Taipale H, Tanskanen A, Tiihonen J, et al. Metformin and risk of alzheimer\u2019s disease among community-dwelling people with diabetes: a National case-control study. J Clin Endocrinol Metab. 2020;105:E963\u201372.","journal-title":"J Clin Endocrinol Metab"},{"key":"529_CR355","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3233\/JAD-2011-101524","volume":"24","author":"CC Hsu","year":"2011","unstructured":"Hsu CC, Wahlqvist ML, Lee MS, Tsai HN. Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and Metformin. J Alzheimer\u2019s Disease. 2011;24:485\u201393.","journal-title":"J Alzheimer\u2019s Disease"},{"key":"529_CR356","doi-asserted-by":"publisher","first-page":"152","DOI":"10.2174\/18756190MTA4dNjE52","volume":"19","author":"J Leszek","year":"2021","unstructured":"Leszek J, Mikhaylenko EV, Belousov DM, Koutsouraki E, Szczechowiak K, Kobusiak-Prokopowicz M, et al. The links between cardiovascular diseases and alzheimer\u2019s disease. Curr Neuropharmacol. 2021;19:152\u201365.","journal-title":"Curr Neuropharmacol"},{"key":"529_CR357","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.jalz.2018.01.007","volume":"14","author":"FJ Wolters","year":"2018","unstructured":"Wolters FJ, Segufa RA, Darweesh SKL, Bos D, Ikram MA, Sabayan B, et al. Coronary heart disease, heart failure, and the risk of dementia: a systematic review and meta-analysis. Alzheimer\u2019s Dement. 2018;14:1493\u2013504.","journal-title":"Alzheimer\u2019s Dement"},{"key":"529_CR358","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cca.2023.117499","volume":"548","author":"W Liu","year":"2023","unstructured":"Liu W, Weng S, Liu H, Cao C, Wang S, Wu S, et al. Serum soluble TREM2 is an independent biomarker associated with coronary heart disease. Clin Chim Acta. 2023;548:1\u20139.","journal-title":"Clin Chim Acta"},{"key":"529_CR359","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1136\/bmj.322.7300.1447","volume":"322","author":"M Kivipelto","year":"2001","unstructured":"Kivipelto M, Helkala EL, Laakso MP, H\u00e4nninen T, Hallikainen M, Alhainen K, et al. Midlife vascular risk factors and alzheimer\u2019s disease in later life: longitudinal, population based study. BMJ. 2001;322:1447.","journal-title":"BMJ"},{"key":"529_CR360","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0197-4580(00)00096-8","volume":"21","author":"LJ Launer","year":"2000","unstructured":"Launer LJ, Ross GW, Petrovitch H, Masaki K, Foley D, White LR, et al. Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging. 2000;21:49\u201355.","journal-title":"Neurobiol Aging"},{"key":"529_CR361","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1212\/01.WNL.0000149519.47454.F2","volume":"64","author":"RA Whitmer","year":"2005","unstructured":"Whitmer RA, Sidney S, Selby J, Claiborne Johnston S, Yaffe K. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology. 2005;64:277\u201381.","journal-title":"Neurology"},{"key":"529_CR362","first-page":"57","volume":"21","author":"H Petrovitch","year":"2000","unstructured":"Petrovitch H, White LR, Izmirilian G, Ross GW, Havlik RJ, Markesbery W, et al. Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Neurobiol Aging. 2000;21:57\u201362.","journal-title":"Neurobiol Aging"},{"key":"529_CR363","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1161\/HYPERTENSIONAHA.111.178962","volume":"59","author":"NS Shah","year":"2012","unstructured":"Shah NS, Vidal JS, Masaki K, Petrovitch H, Webster Ross G, Tilley C, et al. Midlife blood pressure, plasma \u03b2-amyloid, and the risk for alzheimer disease. Hypertension. 2012;59:780\u20136.","journal-title":"Hypertension"},{"key":"529_CR364","doi-asserted-by":"publisher","first-page":"23","DOI":"10.5301\/JN.2010.4729","volume":"24","author":"F Montecucco","year":"2011","unstructured":"Montecucco F, Pende A, Quercioli A, Mach F. Inflammation in the pathophysiology of essential hypertension. J Nephrol. 2011;24:23\u201334.","journal-title":"J Nephrol"},{"key":"529_CR365","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1093\/ajh\/hpab094","volume":"34","author":"J Youwakim","year":"2021","unstructured":"Youwakim J, Girouard H. Inflammation: a mediator between hypertension and neurodegenerative diseases. Am J Hypertens. 2021;34:1014\u201330.","journal-title":"Am J Hypertens"},{"key":"529_CR366","doi-asserted-by":"publisher","first-page":"651215","DOI":"10.3389\/fmolb.2021.651215","volume":"8","author":"JO Hendrickx","year":"2021","unstructured":"Hendrickx JO, Martinet W, Van Dam D, De Meyer GRY. Inflammation, nitro-oxidative stress, impaired autophagy, and insulin resistance as a mechanistic convergence between arterial stiffness and alzheimer\u2019s disease. Front Mol Biosci. 2021;8:651215.","journal-title":"Front Mol Biosci"},{"key":"529_CR367","doi-asserted-by":"publisher","first-page":"749","DOI":"10.3233\/JAD-2010-091561","volume":"20","author":"TF De Alves","year":"2010","unstructured":"De Alves TF, Ferreira TC, Wajngarten LK, Busatto M. Cardiac disorders as risk factors for alzheimer\u2019s disease. J Alzheimer\u2019s Disease. 2010;20:749\u201363.","journal-title":"J Alzheimer\u2019s Disease"},{"key":"529_CR368","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1365-2796.2006.01687.x","volume":"260","author":"MJ Stampfer","year":"2006","unstructured":"Stampfer MJ. Cardiovascular disease and alzheimer\u2019s disease: common links. J Intern Med. 2006;260:211\u201323.","journal-title":"J Intern Med"},{"key":"529_CR369","doi-asserted-by":"crossref","unstructured":"\u2019t Veld BA, Ruitenberg A, Hofman A, Stricker BHC, Breteler MMB, editors. Antihypertensive drugs and incidence of dementia: the Rotterdam Study. Neurobiology of Aging. 2001;22:407\u201312.","DOI":"10.1016\/S0197-4580(00)00241-4"},{"key":"529_CR370","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/S0140-6736(98)03086-4","volume":"352","author":"F Forette","year":"1998","unstructured":"Forette F, Seux ML, Staessen JA, Thijs L, Birkenh\u00e4ger WH, Babarskiene MR, et al. Prevention of dementia in randomised double-blind placebo-controlled systolic hypertension in Europe (Syst-Eur) trial. Lancet. 1998;352:1347\u201351.","journal-title":"Lancet"},{"key":"529_CR371","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1001\/archinte.163.9.1069","volume":"163","author":"C Tzourio","year":"2003","unstructured":"Tzourio C, Anderson C, Chapman N, Woodward M, Neal B, MacMahon S, et al. Effects of blood pressure Lowering with Perindopril and Indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med. 2003;163:1069\u201375.","journal-title":"Arch Intern Med"},{"key":"529_CR372","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/j.1532-5415.2004.52178_7.x","volume":"52","author":"T Ohrui","year":"2004","unstructured":"Ohrui T, Matsui T, Yamaya M, Arai H, Ebihara S, Maruyama M, et al. Angiotensin-converting enzyme inhibitors and incidence of alzheimer\u2019s disease in Japan. J Am Geriatr Soc. 2004;52:649\u201350.","journal-title":"J Am Geriatr Soc"},{"key":"529_CR373","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1001\/archneur.63.5.noc60013","volume":"63","author":"AS Khachaturian","year":"2006","unstructured":"Khachaturian AS, Zandi PP, Lyketsos CG, Hayden KM, Skoog I, Norton MC, et al. Antihypertensive medication use and incident alzheimer disease: the cache County study. Arch Neurol. 2006;63:686\u201392.","journal-title":"Arch Neurol"},{"key":"529_CR374","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1001\/archinte.166.9.1003","volume":"166","author":"C Qiu","year":"2006","unstructured":"Qiu C, Winblad B, Marengoni A, Klarin I, Fastbom J, Fratiglioni L. Heart failure and risk of dementia and alzheimer disease: a population-based cohort study. Arch Intern Med. 2006;166:1003\u20138.","journal-title":"Arch Intern Med"},{"key":"529_CR375","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3233\/JAD-2010-100942","volume":"22","author":"V Frisardi","year":"2010","unstructured":"Frisardi V, Panza F, Seripa D, Imbimbo BP, Vendemiale G, Pilotto A, et al. Nutraceutical properties of mediterranean diet and cognitive decline: possible underlying mechanisms. J Alzheimer\u2019s Disease. 2010;22:715\u201340.","journal-title":"J Alzheimer\u2019s Disease"},{"key":"529_CR376","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1001\/archneur.63.12.noc60109","volume":"63","author":"N Scarmeas","year":"2006","unstructured":"Scarmeas N, Stern Y, Mayeux R, Luchsinger JA. Mediterranean diet, alzheimer disease, and vascular mediation. Arch Neurol. 2006;63:1709\u201317.","journal-title":"Arch Neurol"},{"key":"529_CR377","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1093\/advances\/nmz054","volume":"10","author":"AC n Den Brink","year":"2019","unstructured":"n Den Brink AC, Brouwer-Brolsma EM, Van De Berendsen AAM. The mediterranean, DASH, and MIND diets are associated with less cognitive decline and a lower risk of alzheimer\u2019s disease\u2014A review. Adv Nutr. 2019;10:1040\u201365.","journal-title":"Adv Nutr"},{"key":"529_CR378","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-023-02772-3","volume":"21","author":"OM Shannon","year":"2023","unstructured":"Shannon OM, Ranson JM, Gregory S, Macpherson H, Milte C, Lentjes M, et al. Mediterranean diet adherence is associated with lower dementia risk, independent of genetic predisposition: findings from the UK biobank prospective cohort study. BMC Med. 2023;21:1\u201313.","journal-title":"BMC Med"},{"key":"529_CR379","doi-asserted-by":"publisher","first-page":"E2259","DOI":"10.1212\/WNL.0000000000207176","volume":"100","author":"P Agarwal","year":"2023","unstructured":"Agarwal P, Leurgans SE, Agrawal S, Aggarwal NT, Cherian LJ, James BD, et al. Association of mediterranean-DASH intervention for neurodegenerative delay and mediterranean diets with alzheimer disease pathology. Neurology. 2023;100:E2259\u201368.","journal-title":"Neurology"},{"key":"529_CR380","doi-asserted-by":"publisher","first-page":"6221","DOI":"10.1126\/scitranslmed.aav6221","volume":"11","author":"M Ewers","year":"2019","unstructured":"Ewers M, Franzmeier N, Su\u00e1rez-Calvet M, Morenas-Rodriguez E, Caballero MAA, Kleinberger G, et al. Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in alzheimer\u2019s disease. Sci Transl Med. 2019;11:6221.","journal-title":"Sci Transl Med"},{"key":"529_CR381","doi-asserted-by":"publisher","first-page":"834697","DOI":"10.3389\/fnagi.2021.834697","volume":"13","author":"GC Brown","year":"2022","unstructured":"Brown GC, St George-Hyslop P. Does soluble TREM2 protect against alzheimer\u2019s disease?? Front Aging Neurosci. 2022;13:834697.","journal-title":"Front Aging Neurosci"},{"key":"529_CR382","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1002\/2211-5463.13300","volume":"11","author":"Y Okuzono","year":"2021","unstructured":"Okuzono Y, Sakuma H, Miyakawa S, Ifuku M, Lee J, Das D, et al. Reduced TREM2 activation in microglia of patients with alzheimer\u2019s disease. FEBS Open Bio. 2021;11:3063\u201380.","journal-title":"FEBS Open Bio"},{"key":"529_CR383","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, et al. TREM2 variants in alzheimer\u2019s disease. N Engl J Med. 2013;368:117\u201327.","journal-title":"N Engl J Med"},{"key":"529_CR384","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson T, Stefansson H, Steinberg S, Jonsdottir IV, Jonsson PV, Snaedal J, et al. Variant of TREM2 associated with the risk of alzheimer\u2019s disease. N Engl J Med. 2013;368:107\u201315.","journal-title":"N Engl J Med"},{"key":"529_CR385","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1038\/npp.2014.164","volume":"39","author":"T Jiang","year":"2014","unstructured":"Jiang T, Tan L, Zhu XC, Zhang QQ, Cao L, Tan MS, et al. Upregulation of TREM2 ameliorates neuropathology and rescues Spatial cognitive impairment in a Transgenic mouse model of alzheimer\u2019s disease. Neuropsychopharmacology. 2014;39:2949\u201362.","journal-title":"Neuropsychopharmacology"},{"key":"529_CR386","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1126\/scitranslmed.abq0095","volume":"14","author":"P Zhao","year":"2022","unstructured":"Zhao P, Xu Y, Jiang LL, Fan X, Li L, Li X, et al. A tetravalent TREM2 agonistic antibody reduced amyloid pathology in a mouse model of alzheimer\u2019s disease. Sci Transl Med. 2022;14:95.","journal-title":"Sci Transl Med"},{"key":"529_CR387","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-020-01980-5","volume":"18","author":"M Fassler","year":"2021","unstructured":"Fassler M, Rappaport MS, Cu\u00f1o CB, George J. Engagement of TREM2 by a novel monoclonal antibody induces activation of microglia and improves cognitive function in alzheimer\u2019s disease models. J Neuroinflammation. 2021;18:1\u201318.","journal-title":"J Neuroinflammation"},{"key":"529_CR388","doi-asserted-by":"crossref","unstructured":"Wang S, Mustafa M, Yuede CM, Salazar SV, Kong P, Long H et al. Anti-human TREM2 induces microglia proliferation and reduces pathology in an alzheimer\u2019s disease model. J Exp Med. 2020;217.","DOI":"10.1084\/jem.20200785"},{"key":"529_CR389","doi-asserted-by":"crossref","unstructured":"Schlepckow K, Monroe KM, Kleinberger G, Cantuti-Castelvetri L, Parhizkar S, Xia D et al. Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk region. EMBO Mol Med. 2020;12.","DOI":"10.15252\/emmm.201911227"},{"key":"529_CR390","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.neuron.2020.09.029","volume":"108","author":"JW Lewcock","year":"2020","unstructured":"Lewcock JW, Schlepckow K, Di Paolo G, Tahirovic S, Monroe KM, Haass C. Emerging microglia biology defines novel therapeutic approaches for alzheimer\u2019s disease. Neuron. 2020;108:801\u201321.","journal-title":"Neuron"},{"key":"529_CR391","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-020-01915-0","volume":"17","author":"BR Price","year":"2020","unstructured":"Price BR, Sudduth TL, Weekman EM, Johnson S, Hawthorne D, Woolums A, et al. Therapeutic TREM2 activation ameliorates amyloid-beta deposition and improves cognition in the 5XFAD model of amyloid deposition. J Neuroinflammation. 2020;17:1\u201313.","journal-title":"J Neuroinflammation"},{"key":"529_CR392","first-page":"416","volume":"26","author":"B van Lengerich","year":"2023","unstructured":"van Lengerich B, Zhan L, Xia D, Chan D, Joy DA, Park JI, et al. A TREM2-activating antibody with a blood\u2013brain barrier transport vehicle enhances microglial metabolism in alzheimer\u2019s disease models. Nat Neurosci. 2023;26:416\u201329.","journal-title":"Nat Neurosci"},{"key":"529_CR393","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature11729","volume":"493","author":"MT Heneka","year":"2013","unstructured":"Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, et al. NLRP3 is activated in alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice. Nature. 2013;493:674\u20138.","journal-title":"Nature"},{"key":"529_CR394","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00702-017-1831-7","volume":"125","author":"C Dansokho","year":"2017","unstructured":"Dansokho C, Heneka MT. Neuroinflammatory responses in alzheimer\u2019s disease. J Neural Transm. 2017;125:771\u20139.","journal-title":"J Neural Transm"},{"key":"529_CR395","doi-asserted-by":"crossref","unstructured":"Tejera D, Mercan D, Sanchez-Caro JM, Hanan M, Greenberg D, Soreq H et al. Systemic inflammation impairs microglial A\u03b2 clearance through NLRP3 inflammasome. EMBO J. 2019;38.","DOI":"10.15252\/embj.2018101064"},{"key":"529_CR396","first-page":"3574","volume":"168","author":"D Jha","year":"2023","unstructured":"Jha D, Bakker ENTP, Kumar R. Mechanistic and therapeutic role of NLRP3 inflammasome in the pathogenesis of alzheimer\u2019s disease. J Neurochem. 2023;168:3574\u201398.","journal-title":"J Neurochem"},{"key":"529_CR397","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s44337-025-00220-0","volume":"2","author":"AS Yehualashet","year":"2025","unstructured":"Yehualashet AS, Melaku EE, Gebreyes DS, Wassie TA, Sahilu BY. The bilateral cross communication in microbiota-gut-brain axis as a promising therapeutic target for alzheimer\u2019s disease: a focus on neuroinflammation. Discover Med. 2025;2:1\u201314.","journal-title":"Discover Med"},{"key":"529_CR398","doi-asserted-by":"publisher","first-page":"5480","DOI":"10.1523\/JNEUROSCI.0200-20.2020","volume":"40","author":"MMS Beyer","year":"2020","unstructured":"Beyer MMS, Lonnemann N, Remus A, Latz E, Heneka MT, Korte M. Enduring changes in neuronal function upon systemic inflammation are NLRP3 inflammasome dependent. J Neurosci. 2020;40:5480\u201394.","journal-title":"J Neurosci"},{"key":"529_CR399","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-24350-x","volume":"8","author":"S Ismael","year":"2018","unstructured":"Ismael S, Zhao L, Nasoohi S, Ishrat T. Inhibition of the NLRP3-inflammasome as a potential approach for neuroprotection after stroke. Sci Rep. 2018;8:1\u20139.","journal-title":"Sci Rep"},{"key":"529_CR400","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1007\/s12035-023-03618-y","volume":"61","author":"B Hou","year":"2024","unstructured":"Hou B, Yin J, Liu S, Guo J, Zhang B, Zhang Z, et al. Inhibiting the NLRP3 inflammasome with MCC950 alleviates neurological impairment in the brain of EAE mice. Mol Neurobiol. 2024;61:1318\u201330.","journal-title":"Mol Neurobiol"},{"key":"529_CR401","doi-asserted-by":"crossref","unstructured":"Daniels MJD, Rivers-Auty J, Schilling T, Spencer NG, Watremez W, Fasolino V et al. Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against alzheimer\u2019s disease in rodent models. Nat Commun. 2016;7.","DOI":"10.1038\/ncomms12504"},{"key":"529_CR402","first-page":"e12314","volume":"14","author":"FH Bouwman","year":"2022","unstructured":"Bouwman FH, Frisoni GB, Johnson SC, Chen X, Engelborghs S, Ikeuchi T, et al. Clinical application of CSF biomarkers for alzheimer\u2019s disease: from rationale to ratios. Alzheimer\u2019s Dement. 2022;14:e12314.","journal-title":"Alzheimer\u2019s Dement"},{"key":"529_CR403","doi-asserted-by":"publisher","first-page":"9690","DOI":"10.1038\/s41467-024-53547-0","volume":"15","author":"E Lobanova","year":"2024","unstructured":"Lobanova E, Zhang YP, Emin D, Brelstaff J, Kahanawita L, Malpetti M, Quaegebeur A, Triantafilou K, Triantafilou M, Zetterberg H, Rowe JB, Williams-Gray CH, Bryant CE, Klenerman D. ASC specks as a single-molecule fluid biomarker of inflammation in neurodegenerative diseases. Nat Commun. 2024;15:9690.","journal-title":"Nat Commun"},{"key":"529_CR404","doi-asserted-by":"publisher","first-page":"7758","DOI":"10.3390\/ijms25147758","volume":"25","author":"B Cyr","year":"2024","unstructured":"Cyr B, Curiel Cid R, Loewenstein D, Vontell RT, Dietrich WD, Keane RW, de Rivero Vaccari JP. The inflammasome adaptor protein ASC in plasma as a biomarker of early cognitive changes. Int J Mol Sci. 2024;25:7758.","journal-title":"Int J Mol Sci"},{"key":"529_CR405","doi-asserted-by":"publisher","first-page":"4674","DOI":"10.3390\/ijms21134674","volume":"21","author":"XO Scott","year":"2020","unstructured":"Scott XO, Stephens ME, Desir MC, Dietrich WD, Keane RW, de Rivero Vaccari JP. The inflammasome adaptor protein ASC in mild cognitive impairment and alzheimer\u2019s disease. Int J Mol Sci. 2020;21:4674.","journal-title":"Int J Mol Sci"},{"key":"529_CR406","doi-asserted-by":"publisher","first-page":"466","DOI":"10.15252\/emmm.201506123","volume":"8","author":"M Su\u00e1rez-Calvet","year":"2016","unstructured":"Su\u00e1rez-Calvet M, Kleinberger G, Araque Caballero M\u00c1, Brendel M, Rominger A, Alcolea D, et al. sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage alzheimer\u2019s disease and associate with neuronal injury markers. EMBO Mol Med. 2016;8:466\u201376.","journal-title":"EMBO Mol Med"},{"key":"529_CR407","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s13311-022-01185-z","volume":"19","author":"R Duara","year":"2022","unstructured":"Duara R, Barker W. Heterogeneity in alzheimer\u2019s disease diagnosis and progression rates: implications for therapeutic trials. Neurotherapeutics. 2022;19:8\u201318.","journal-title":"Neurotherapeutics"}],"container-title":["Immunity & Ageing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12979-025-00529-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12979-025-00529-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12979-025-00529-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T10:09:32Z","timestamp":1757412572000},"score":1,"resource":{"primary":{"URL":"https:\/\/immunityageing.biomedcentral.com\/articles\/10.1186\/s12979-025-00529-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":407,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["529"],"URL":"https:\/\/doi.org\/10.1186\/s12979-025-00529-5","relation":{},"ISSN":["1742-4933"],"issn-type":[{"value":"1742-4933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]},"assertion":[{"value":"14 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33"}}